D. A. , Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI, J. Alzheimers Dis, vol.23, pp.257-269, 2011.

A. Andreani, A. Leoni, A. Locatelli, R. Morigi, M. Rambaldi et al., 4-Aminopyridine derivatives with antiamnesic activity, Eur J Med Chem, vol.35, pp.77-82, 2000.

N. Andrieu-abadie, V. Gouazé, R. Salvayre, and T. Levade, Ceramide in apoptosis signaling: relationship with oxidative stress. Free Radic, Biol. Med, vol.31, pp.717-728, 2001.

M. C. Angulo, K. Le-meur, A. S. Kozlov, S. Charpak, A. et al., GABA, a forgotten gliotransmitter, Prog. Neurobiol, vol.86, pp.297-303, 2008.

G. Astarita, K. Jung, N. C. Berchtold, V. Q. Nguyen, D. L. Gillen et al., Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease, PLoS ONE, vol.5, 2010.

C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. Bacarra et al., Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J. Biol. Chem, vol.273, pp.12817-12826, 1998.

C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. Bacarra et al., Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J. Biol. Chem, vol.273, pp.12817-12826, 1998.

M. V. Avshalumov and M. E. Rice, Activation of ATP-sensitive K+ (K(ATP)) channels by H2O2 underlies glutamate-dependent inhibition of striatal dopamine release, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.11729-11734, 2003.

M. Baarine, P. Andréoletti, A. Athias, T. Nury, A. Zarrouk et al., Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins, Neuroscience, vol.213, pp.1-18, 2012.

M. Baarine, K. Ragot, E. C. Genin, H. El-hajj, D. Trompier et al., Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes, J. Neurochem, vol.111, pp.119-131, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00514890

R. S. Balaban, S. Nemoto, and T. Finkel, Mitochondria, oxidants, and aging, Cell, vol.120, pp.483-495, 2005.

N. Balasubramanian, D. W. Scott, J. D. Castle, J. E. Casanova, and M. A. Schwartz, Arf6 and microtubules in adhesion-dependent trafficking of lipid rafts, Nat. Cell Biol, vol.9, pp.1381-1391, 2007.

S. J. Baloyannis, Mitochondrial alterations in Alzheimer's disease, J. Alzheimers Dis, vol.9, pp.119-126, 2006.

J. L. Bankers-fulbright, G. M. Kephart, D. A. Loegering, A. L. Bradford, S. Okada et al., Sulfonylureas inhibit cytokine-induced eosinophil survival and activation, J. Immunol, vol.160, pp.5546-5553, 1998.

G. Barceló-coblijn, K. Kitajka, L. G. Puskás, E. Hogyes, A. Zvara et al., Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio, Biochim. Biophys. Acta, vol.1632, pp.72-79, 2003.

A. J. Barela, S. P. Waddy, J. G. Lickfett, J. Hunter, A. Anido et al., An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability, J. Neurosci, vol.26, pp.2714-2723, 2006.

S. Barghorn and E. Mandelkow, Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments, Biochemistry, vol.41, pp.14885-14896, 2002.

R. Barouki, , 2006.

, Med Sci, vol.22, pp.266-272

B. A. Barres, Glial ion channels, Curr. Opin. Neurobiol, vol.1, pp.354-359, 1991.

B. A. Barres and S. J. Smith, Neurobiology. Cholesterol--making or breaking the synapse, Science, vol.294, pp.1296-1297, 2001.

B. M. Barth, S. J. Gustafson, J. L. Hankins, J. M. Kaiser, J. K. Haakenson et al., Ceramide kinase regulates TNF?-stimulated NADPH oxidase activity and eicosanoid biosynthesis in neuroblastoma cells, Cell. Signal, vol.24, pp.1126-1133, 2012.

G. Bartzokis, Alzheimer's disease as homeostatic responses to age-related myelin breakdown, Neurobiol. Aging, vol.32, pp.1341-1371, 2011.

G. Bartzokis, P. H. Lu, K. Tingus, M. F. Mendez, A. Richard et al., Lifespan trajectory of myelin integrity and maximum motor speed, Neurobiol. Aging, vol.31, pp.1554-1562, 2010.

G. Basurto-islas, J. Luna-muñoz, A. L. Guillozet-bongaarts, L. I. Binder, R. Mena et al., Accumulation of aspartic acid421-and glutamic acid391-cleaved tau in neurofibrillary tangles correlates with progression in Alzheimer disease, J. Neuropathol. Exp. Neurol, vol.67, pp.470-483, 2008.

P. E. Batchelor, M. J. Porritt, P. Martinello, C. L. Parish, G. T. Liberatore et al., Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge, Mol. Cell. Neurosci, vol.21, pp.436-453, 2002.

D. R. Bauman, A. D. Bitmansour, J. G. Mcdonald, B. M. Thompson, G. Liang et al., 25-Hydroxycholesterol secreted by macrophages in response to Tolllike receptor activation suppresses immunoglobulin A production, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.16764-16769, 2009.

N. G. Bazan, Cellular and molecular events mediated by docosahexaenoic acidderived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection, Prostaglandins Leukot. Essent. Fatty Acids, vol.81, pp.205-211, 2009.

W. W. Beatty, D. P. Salmon, N. Butters, W. C. Heindel, and E. L. Granholm, Retrograde amnesia in patients with Alzheimer's disease or Huntington's disease, Neurobiol. Aging, vol.9, pp.181-186, 1988.

C. Béchade, Y. Cantaut-belarif, and A. Bessis, Microglial control of neuronal activity, Front Cell Neurosci, vol.7, p.32, 2013.

K. B. Beckman and B. N. Ames, Mitochondrial aging: open questions, Ann. N. Y. Acad. Sci, vol.854, pp.118-127, 1998.

C. Beeton, J. Barbaria, P. Giraud, J. Devaux, A. M. Benoliel et al., Selective blocking of voltage-gated K+ channels improves experimental autoimmune encephalomyelitis and inhibits T cell activation, J. Immunol, vol.166, pp.936-944, 2001.

G. Behrendt, K. Baer, A. Buffo, M. A. Curtis, R. L. Faull et al., Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men, Glia, vol.61, pp.273-286, 2013.

B. A. Benitez and C. Cruchaga, TREM2 and neurodegenerative disease, N. Engl. J. Med, vol.369, pp.1567-1568, 2013.

T. Berger, J. Schnitzer, P. M. Orkand, and H. Kettenmann, Sodium and Calcium Currents in Glial Cells of the Mouse Corpus Callosum Slice, Eur. J. Neurosci, vol.4, pp.1271-1284, 1992.

C. Berthet, H. Lei, J. Thevenet, R. Gruetter, P. J. Magistretti et al., Neuroprotective role of lactate after cerebral ischemia, J. Cereb. Blood Flow Metab, vol.29, pp.1780-1789, 2009.

A. Berthier, S. Lemaire-ewing, C. Prunet, S. Monier, A. Athias et al., Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis, Cell Death Differ, vol.11, pp.897-905, 2004.

L. Bertram and R. E. Tanzi, The current status of Alzheimer's disease genetics: what do we tell the patients?, Pharmacol. Res, vol.50, pp.385-396, 2004.

F. Bezanilla, Voltage sensor movements, J. Gen. Physiol, vol.120, pp.465-473, 2002.

I. Bezprozvanny and M. P. Mattson, Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease, Trends Neurosci, vol.31, pp.454-463, 2008.

L. Bianchi and M. Driscoll, Heterologous expression of C. elegans ion channels in Xenopus oocytes, pp.1-16, 2006.

K. Biber, T. Owens, and E. Boddeke, What is microglia neurotoxicity (Not)?, Glia, vol.62, pp.841-854, 2014.

N. Bien-ly, C. A. Boswell, S. Jeet, T. G. Beach, K. Hoyte et al., Lack of Widespread BBB Disruption in Alzheimer's Disease Models: Focus on Therapeutic Antibodies, Neuron, vol.88, pp.289-297, 2015.

C. Bionda, J. Portoukalian, D. Schmitt, C. Rodriguez-lafrasse, A. et al., , 2004.

, Subcellular compartmentalization of ceramide metabolism: MAM (mitochondriaassociated membrane) and/or mitochondria?, Biochem. J, vol.382, pp.527-533

H. Birbes, C. Luberto, Y. Hsu, S. Bawab, Y. A. Hannun et al., A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria, Biochem. J, vol.386, pp.445-451, 2005.

I. Björkhem, Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain, J. Intern. Med, vol.260, pp.493-508, 2006.

I. Björkhem and U. Diczfalusy, Oxysterols: friends, foes, or just fellow passengers?, Arterioscler. Thromb. Vasc. Biol, vol.22, pp.734-742, 2002.

I. Björkhem and S. Meaney, Brain cholesterol: long secret life behind a barrier, Arterioscler. Thromb. Vasc. Biol, vol.24, pp.806-815, 2004.

I. Bjorkhem, U. Andersson, E. Ellis, G. Alvelius, L. Ellegard et al., From brain to bile. Evidence that conjugation and omegahydroxylation are important for elimination of 24S-hydroxycholesterol (cerebrosterol) in humans, J. Biol. Chem, vol.276, pp.37004-37010, 2001.

I. Björkhem, A. Cedazo-minguez, V. Leoni, and S. Meaney, Oxysterols and neurodegenerative diseases, Mol. Aspects Med, vol.30, pp.171-179, 2009.

I. Björkhem, E. Lund, and M. Rudling, Coordinate regulation of cholesterol 7 alphahydroxylase and HMG-CoA reductase in the liver, Subcell. Biochem, vol.28, pp.23-55, 1997.

V. H. Black, Cytochrome P450s in the guinea pig adrenal that are immunologically similar to liver forms: estrogen suppression explains male-female differences, J. Steroid Biochem. Mol. Biol, vol.43, pp.863-868, 1992.

E. Blasi, R. Barluzzi, V. Bocchini, R. Mazzolla, and F. Bistoni, Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus, J. Neuroimmunol, vol.27, pp.229-237, 1990.

M. L. Block and J. Hong, Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism, Prog. Neurobiol, vol.76, pp.77-98, 2005.

M. L. Block, L. Zecca, and J. Hong, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat. Rev. Neurosci, vol.8, pp.57-69, 2007.

E. Boda, E. Hoxha, A. Pini, F. Montarolo, and F. Tempia, Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease, J. Mol. Neurosci, vol.46, pp.606-615, 2012.

K. Bodin, L. Bretillon, Y. Aden, L. Bertilsson, U. Broomé et al., Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4, J. Biol. Chem, vol.276, pp.38685-38689, 2001.

N. Bogdanovic, L. Bretillon, E. G. Lund, U. Diczfalusy, L. Lannfelt et al., On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells, Neurosci. Lett, vol.314, pp.45-48, 2001.

D. Boison, H. Büssow, D. D'urso, H. W. Müller, and W. Stoffel, Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths, J. Neurosci, vol.15, pp.5502-5513, 1995.

A. Bordey and H. Sontheimer, Ion channel expression by astrocytes in situ: comparison of different CNS regions, Glia, vol.30, pp.27-38, 2000.

D. S. Bortone, K. Mitchell, and P. B. Manis, Developmental time course of potassium channel expression in the rat cochlear nucleus, Hear. Res, vol.211, pp.114-125, 2006.

F. Bosetti, F. Brizzi, S. Barogi, M. Mancuso, G. Siciliano et al., Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease, Neurobiol. Aging, vol.23, pp.371-376, 2002.
DOI : 10.1016/s0197-4580(01)00314-1

H. Braak and E. Braak, Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections, Brain Pathol, vol.1, pp.213-216, 1991.

H. Braak and E. Braak, Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis, Acta Neuropathol, vol.92, pp.197-201, 1996.

H. Braak, R. A. De-vos, E. N. Jansen, H. Bratzke, and E. Braak, Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog, Brain Res, vol.117, pp.267-285, 1998.

M. Bradl and H. Lassmann, Oligodendrocytes: biology and pathology, Acta Neuropathol, vol.119, pp.37-53, 2010.
DOI : 10.1007/s00401-009-0601-5

URL : https://link.springer.com/content/pdf/10.1007%2Fs00401-009-0601-5.pdf

G. T. Bramblett, J. Q. Trojanowski, and V. M. Lee, Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms, 1992.

, Lab. Invest, vol.66, pp.212-222

W. C. Breckenridge, G. Gombos, and I. G. Morgan, The lipid composition of adult rat brain synaptosomal plasma membranes, Biochim. Biophys. Acta, vol.266, pp.695-707, 1972.

J. T. Brenna, Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man, Curr Opin Clin Nutr Metab Care, vol.5, pp.127-132, 2002.

L. Bretillon, U. Diczfalusy, I. Björkhem, M. A. Maire, L. Martine et al., Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina, Curr. Eye Res, vol.32, pp.361-366, 2007.

Y. H. Chang, D. S. Abdalla, and A. Sevanian, Characterization of cholesterol oxidation products formed by oxidative modification of low density lipoprotein. Free Radic, Biol. Med, vol.23, pp.202-214, 1997.

S. Chatterjee, Neutral sphingomyelinase: past, present and future, Chem. Phys. Lipids, vol.102, pp.79-96, 1999.
DOI : 10.1016/s0009-3084(99)00077-8

A. K. Chaudhary, G. R. Reddy, I. A. Blair, and L. J. Marnett, Characterization of an N6-oxopropenyl-2'-deoxyadenosine adduct in malondialdehyde-modified DNA using liquid chromatography/electrospray ionization tandem mass spectrometry, Carcinogenesis, vol.17, pp.1167-1170, 1996.

N. B. Chauhan, J. M. Lee, and G. J. Siegel, Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease, J. Mol. Neurosci, vol.9, pp.151-166, 1997.

F. Chauveau, H. Boutin, N. Van-camp, C. Thominiaux, P. Hantraye et al., In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa), Eur. J. Nucl. Med. Mol. Imaging, vol.38, pp.509-514, 2011.

K. Chen, S. R. Thomas, and J. F. Keaney, Beyond LDL oxidation: ROS in vascular signal transduction. Free Radic, Biol. Med, vol.35, pp.117-132, 2003.

H. Cheng, K. S. Vetrivel, P. Gong, X. Meckler, A. Parent et al., Mechanisms of disease: new therapeutic strategies for Alzheimer's disease--targeting APP processing in lipid rafts, Nat Clin Pract Neurol, vol.3, pp.374-382, 2007.

J. Y. Chiang, Regulation of bile acid synthesis, Front. Biosci, vol.3, pp.176-193, 1998.

L. S. Chin, C. C. Park, K. M. Zitnay, M. Sinha, A. J. Dipatri et al., 4-Aminopyridine causes apoptosis and blocks an outward rectifier K+ channel in malignant astrocytoma cell lines, J. Neurosci. Res, vol.48, pp.122-127, 1997.

S. Y. Chiu, R. , and J. M. , Potassium channels in nodal and internodal axonal membrane of mammalian myelinated fibres, Nature, vol.284, pp.170-171, 1980.

E. K. Choi, N. F. Zaidi, J. S. Miller, A. C. Crowley, D. E. Merriam et al., Calsenilin is a substrate for caspase-3 that preferentially interacts with the familial Alzheimer's disease-associated C-terminal fragment of presenilin 2, J. Biol. Chem, vol.276, pp.19197-19204, 2001.

Y. Christen, Oxidative stress and Alzheimer disease, Am. J. Clin. Nutr, vol.71, pp.621-629, 2000.

S. Chung, J. Lee, E. H. Joe, and D. Y. Uhm, Beta-amyloid peptide induces the expression of voltage dependent outward rectifying K+ channels in rat microglia, Neurosci. Lett, vol.300, pp.67-70, 2001.

Y. H. Chung, C. M. Shin, M. J. Kim, and C. I. Cha, Immunohistochemical study on the distribution of six members of the Kv1 channel subunits in the rat basal ganglia, Brain Res, vol.875, pp.164-170, 2000.

A. Cimini, S. Moreno, M. D'amelio, L. Cristiano, B. D'angelo et al., Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes, J. Alzheimers Dis, vol.18, pp.935-952, 2009.

M. Citron, Strategies for disease modification in Alzheimer's disease, Nat. Rev. Neurosci, vol.5, pp.677-685, 2004.

D. W. Cleveland, S. Y. Hwo, and M. W. Kirschner, Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly, J. Mol. Biol, vol.116, pp.227-247, 1977.

L. K. Clinton, M. Blurton-jones, K. Myczek, J. Q. Trojanowski, and F. M. Laferla, , 2010.

, Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline, J. Neurosci, vol.30, pp.7281-7289

N. R. Coe, A. J. Smith, B. I. Frohnert, P. A. Watkins, and D. A. Bernlohr, The fatty acid transport protein (FATP1) is a very long chain acyl-CoA synthetase, J. Biol. Chem, vol.274, pp.36300-36304, 1999.

F. Colciaghi, B. Borroni, L. Pastorino, E. Marcello, M. Zimmermann et al., Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients, vol.8, pp.67-74, 2002.

G. M. Cole and S. A. Frautschy, DHA may prevent age-related dementia, J. Nutr, vol.140, pp.869-874, 2010.

L. V. Colom, M. E. Diaz, D. R. Beers, A. Neely, W. J. Xie et al., Role of potassium channels in amyloid-induced cell death, J. Neurochem, vol.70, pp.1925-1934, 1998.

L. Colombaioni and M. Garcia-gil, Sphingolipid metabolites in neural signalling and function, Brain Res. Brain Res. Rev, vol.46, pp.328-355, 2004.

R. A. Colvin, J. W. Bennett, and S. L. Colvin, Na(+)-Ca2+ exchange activity is increased in Alzheimer's disease brain tissues, Ann. N. Y. Acad. Sci, vol.639, pp.325-327, 1991.

J. A. Conquer and B. J. Holub, Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores, Lipids, vol.32, pp.341-345, 1997.

M. S. Cooke, M. D. Evans, M. Dizdaroglu, and J. Lunec, Oxidative DNA damage: mechanisms, mutation, and disease, FASEB J, vol.17, pp.1195-1214, 2003.

E. Coppi, L. Cellai, G. Maraula, I. Dettori, A. Melani et al., Role of adenosine in oligodendrocyte precursor maturation, Front Cell Neurosci, vol.9, p.155, 2015.

E. Coppi, L. Cellai, G. Maraula, A. M. Pugliese, and F. Pedata, Adenosine A?A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures, Neuropharmacology, vol.73, pp.301-310, 2013.

E. Coppi, G. Maraula, M. Fumagalli, P. Failli, L. Cellai et al., UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors, Glia, vol.61, pp.1155-1171, 2013.

D. Cotella, B. Hernandez-enriquez, X. Wu, R. Li, Z. Pan et al., Toxic role of K+ channel oxidation in mammalian brain, J. Neurosci, vol.32, pp.4133-4144, 2012.

M. L. Cotrina and M. Nedergaard, Physiological and pathological functions of P2X7 receptor in the spinal cord, Purinergic Signal, vol.5, pp.223-232, 2009.

J. A. Coull, S. Beggs, D. Boudreau, D. Boivin, M. Tsuda et al., BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain, Nature, vol.438, pp.1017-1021, 2005.

M. C. Craig and D. G. Murphy, Estrogen therapy and Alzheimer's dementia, Ann. N. Y. Acad. Sci, vol.1205, pp.245-253, 2010.

P. J. Crick, W. J. Griffiths, J. Zhang, M. Beibel, J. Abdel-khalik et al., Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients, Mol. Neurobiol, 2016.

A. Crotti and R. M. Ransohoff, Microglial Physiology and Pathophysiology: Insights from Genome-wide Transcriptional Profiling, Immunity, vol.44, pp.505-515, 2016.

S. C. Cunnane, M. Plourde, F. Pifferi, M. Bégin, C. Féart et al., , 2009.

. Fish, Alzheimer's disease, Prog. Lipid Res, vol.48, pp.239-256

O. Cuvillier, N. Andrieu-abadie, B. Ségui, S. Malagarie-cazenave, C. Tardy et al., , 2003.

, J. Soc. Biol, vol.197, pp.217-221

M. D'amelio, V. Cavallucci, S. Middei, C. Marchetti, S. Pacioni et al., Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease, Nat. Neurosci, vol.14, pp.69-76, 2011.

B. D'autréaux and M. B. Toledano, ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis, Nat. Rev. Mol. Cell Biol, vol.8, pp.813-824, 2007.

C. Dart, Lipid microdomains and the regulation of ion channel function, J. Physiol. (Lond.), vol.588, pp.3169-3178, 2010.

J. Dartigues, C. Helmer, L. Letenneur, K. Péres, H. Amieva et al., , 2012.

, Geriatr Psychol Neuropsychiatr Vieil, vol.10, pp.325-331

J. Dartigues, C. Helmer, L. Letenneur, K. Péres, H. Amieva et al., , 2012.

, Geriatr Psychol Neuropsychiatr Vieil, vol.10, pp.325-331

B. Dasari, J. R. Prasanthi, G. Marwarha, B. B. Singh, and O. Ghribi, The oxysterol 27-hydroxycholesterol increases ?-amyloid and oxidative stress in retinal pigment epithelial cells, BMC Ophthalmol, vol.10, p.22, 2010.

N. Dascal, The use of Xenopus oocytes for the study of ion channels, CRC Crit. Rev. Biochem, vol.22, pp.317-387, 1987.

D. Davalos, J. Grutzendler, G. Yang, J. V. Kim, Y. Zuo et al., ATP mediates rapid microglial response to local brain injury in vivo, Nat. Neurosci, vol.8, pp.752-758, 2005.

M. J. Davies, Singlet oxygen-mediated damage to proteins and its consequences, Biochem. Biophys. Res. Commun, vol.305, pp.761-770, 2003.
DOI : 10.1016/s0006-291x(03)00817-9

M. R. Dawson, A. Polito, J. M. Levine, R. , and R. , NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS, Mol. Cell. Neurosci, vol.24, pp.476-488, 2003.

E. I. De-chaves, A. E. Rusiñol, D. E. Vance, R. B. Campenot, and J. E. Vance, Role of lipoproteins in the delivery of lipids to axons during axonal regeneration, J. Biol. Chem, vol.272, pp.30766-30773, 1997.

M. C. De-lacoste and C. L. White, The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system, Neurobiol. Aging, vol.14, pp.1-16, 1993.

G. R. De-lores-arnaiz and M. G. Ordieres, Brain Na(+), K(+)-ATPase Activity In Aging and Disease, Int J Biomed Sci, vol.10, pp.85-102, 2014.

P. De-medina, M. R. Paillasse, G. Segala, T. Saati, J. Boyes et al., Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A, Biochimie, vol.95, pp.482-488, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00822283

P. De-medina, M. R. Paillasse, G. Segala, M. Voisin, L. Mhamdi et al., Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat Commun, vol.4, p.1840, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00823974

J. M. Dean, M. D. Moravec, M. Grafe, N. Abend, J. Ren et al., Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human, Dev. Neurosci, vol.33, pp.251-260, 2011.

M. Debbabi, T. Nury, A. Zarrouk, N. Mekahli, M. Bezine et al., Protective Effects of ?-Tocopherol, ?-Tocopherol and Oleic Acid, Three Compounds of Olive Oils, and No Effect of Trolox, on 7-Ketocholesterol-Induced Mitochondrial and Peroxisomal Dysfunction in Microglial BV-2 Cells, Int J Mol Sci, vol.17, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01463786

A. Delacourte, Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias, Dement Geriatr Cogn Disord, vol.10, pp.75-79, 1999.

A. Delacourte and A. Defossez, Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments, J. Neurol. Sci, vol.76, pp.173-186, 1986.

L. A. Demetrius, P. J. Magistretti, and L. Pellerin, Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect, Front Physiol, vol.5, p.522, 2014.

M. K. Desai, B. J. Guercio, W. C. Narrow, and W. J. Bowers, An Alzheimer's diseaserelevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction, Glia, vol.59, pp.627-640, 2011.

J. Devaux, G. Alcaraz, J. Grinspan, V. Bennett, R. Joho et al., Kv3.1b is a novel component of CNS nodes, J. Neurosci, vol.23, pp.4509-4518, 2003.
URL : https://hal.archives-ouvertes.fr/hal-00966188

L. Devi, B. M. Prabhu, D. F. Galati, N. G. Avadhani, and H. K. Anandatheerthavarada, Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction, J. Neurosci, vol.26, pp.9057-9068, 2006.

M. Díaz-hernández, M. Díez-zaera, J. Sánchez-nogueiro, R. Gómez-villafuertes, J. M. Canals et al., Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration, FASEB J, vol.23, pp.1893-1906, 2009.

D. W. Dickson, Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies, Neurobiol. Aging, vol.18, pp.21-26, 1997.

A. Diestel, O. Aktas, D. Hackel, I. Hake, S. Meier et al., Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage, J. Exp. Med, vol.198, pp.1729-1740, 2003.

J. M. Dietschy and S. D. Turley, Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal, J. Lipid Res, vol.45, pp.1375-1397, 2004.

M. Dizdaroglu, Facts about the artifacts in the measurement of oxidative DNA base damage by gas chromatography-mass spectrometry, Free Radic. Res, vol.29, pp.551-563, 1998.

J. J. Donkin, S. Stukas, V. Hirsch-reinshagen, D. Namjoshi, A. Wilkinson et al., ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice, J. Biol. Chem, vol.285, pp.34144-34154, 2010.

C. G. Dotti, C. A. Sullivan, and G. A. Banker, The establishment of polarity by hippocampal neurons in culture, J. Neurosci, vol.8, pp.1454-1468, 1988.

J. L. Doyle and L. Stubbs, Ataxia, arrhythmia and ion-channel gene defects, Trends Genet, vol.14, pp.92-98, 1998.

W. Dröge, Free radicals in the physiological control of cell function, Physiol. Rev, vol.82, pp.47-95, 2002.

W. Dröge, The plasma redox state and ageing, Ageing Res. Rev, vol.1, pp.257-278, 2002.

F. Duprat, C. Girard, G. Jarretou, and M. Lazdunski, Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species, J. Physiol, vol.562, pp.235-244, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00091091

M. J. Duran, S. V. Pierre, P. Lesnik, G. Pieroni, M. Bourdeaux et al., 7-ketocholesterol inhibits Na,K-ATPase activity by decreasing expression of its ?1-subunit and membrane fluidity in human endothelial cells, Cell. Mol. Biol, vol.56, pp.1434-1441, 2010.

C. Duyckaerts, J. J. Hauw, F. Piette, C. Rainsard, V. Poulain et al., Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length, Acta Neuropathol, vol.66, pp.72-74, 1985.

R. G. Dyer, M. W. Stewart, J. Mitcheson, K. George, M. M. Alberti et al., 7-ketocholesterol, a specific indicator of lipoprotein oxidation, and malondialdehyde in non-insulin dependent diabetes and peripheral vascular disease, Clin. Chim. Acta, vol.260, pp.1-13, 1997.

N. Edgar and E. Sibille, A putative functional role for oligodendrocytes in mood regulation, Transl Psychiatry, vol.2, p.109, 2012.

P. A. Edwards, M. A. Kennedy, and P. A. Mak, LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis, Vascul. Pharmacol, vol.38, pp.249-256, 2002.

F. Eichler and K. Van-haren, Immune response in leukodystrophies, Pediatr. Neurol, vol.37, pp.235-244, 2007.

S. Elkabes, E. M. Dicicco-bloom, and I. B. Black, Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function, 1996.

, J. Neurosci, vol.16, pp.2508-2521

B. Emery, Regulation of oligodendrocyte differentiation and myelination, Science, vol.330, pp.779-782, 2010.

M. Engelen, S. Kemp, and B. Poll-the, X-linked adrenoleukodystrophy: pathogenesis and treatment, Curr Neurol Neurosci Rep, vol.14, p.486, 2014.
DOI : 10.1007/s11910-014-0486-0

M. M. Esiri, Ageing and the brain, J. Pathol, vol.211, pp.181-187, 2007.

M. M. Esiri, G. K. Wilcock, and J. H. Morris, Neuropathological assessment of the lesions of significance in vascular dementia, J. Neurol. Neurosurg. Psychiatr, vol.63, pp.749-753, 1997.

F. Espinosa, G. Marks, N. Heintz, and R. H. Joho, Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels, Genes Brain Behav, vol.3, pp.90-100, 2004.

F. Espinosa, A. Mcmahon, E. Chan, S. Wang, C. S. Ho et al., Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3, J. Neurosci, vol.21, pp.6657-6665, 2001.

E. Esposito, D. Rotilio, V. Di-matteo, C. Di-giulio, M. Cacchio et al., A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes, Neurobiol. Aging, vol.23, pp.719-735, 2002.

H. Esterbauer, J. Gebicki, H. Puhl, and G. Jürgens, The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic, Biol. Med, vol.13, pp.341-390, 1992.

B. Ettle, J. C. Schlachetzki, and J. Winkler, Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?, Mol. Neurobiol, vol.53, pp.3046-3062, 2016.

V. Eulenburg and J. Gomeza, Neurotransmitter transporters expressed in glial cells as regulators of synapse function, Brain Res Rev, vol.63, pp.103-112, 2010.

W. J. Evans, Vitamin E, vitamin C, and exercise, Am. J. Clin. Nutr, vol.72, pp.647-52, 2000.

U. B. Eyo and L. Wu, Bidirectional microglia-neuron communication in the healthy brain, Neural Plast, p.456857, 2013.

E. Fahy, S. Subramaniam, H. A. Brown, C. K. Glass, A. H. Merrill et al., A comprehensive classification system for lipids, J. Lipid Res, vol.46, pp.839-861, 2005.

F. Fanelli, S. Sepe, M. D'amelio, C. Bernardi, L. Cristiano et al., Age-dependent roles of peroxisomes in the hippocampus of a transgenic mouse model of Alzheimer's disease, Mol Neurodegener, vol.8, 2013.

R. L. Farr, C. Lismont, S. R. Terlecky, and M. Fransen, Peroxisome biogenesis in mammalian cells: The impact of genes and environment, Biochim. Biophys. Acta, vol.1863, pp.1049-1060, 2016.

S. E. Feller, Acyl chain conformations in phospholipid bilayers: a comparative study of docosahexaenoic acid and saturated fatty acids, Chem. Phys. Lipids, vol.153, pp.76-80, 2008.

J. J. Feng and D. K. Morest, Development of synapses and expression of a voltagegated potassium channel in chick embryonic auditory nuclei, Hear. Res, pp.116-126, 2006.

J. Ferent, M. Ruat, and E. Traiffort, Investigation of the proteolipid protein promoter activity during demyelination and repair, Differentiation, vol.85, pp.182-189, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00851056

J. D. Fernstrom, Effects of dietary polyunsaturated fatty acids on neuronal function, 1999.

A. Lobo, J. Martinez-lage, H. Soininen, and A. Hofman, Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group, Neurology, vol.54, pp.10-15, 2000.

V. Frazzini, S. Guarnieri, M. Bomba, R. Navarra, C. Morabito et al., Altered Kv2.1 functioning promotes increased excitability in hippocampal neurons of an Alzheimer's disease mouse model, Cell Death Dis, vol.7, 2016.

Y. Freund-levi, M. Eriksdotter-jönhagen, T. Cederholm, H. Basun, G. Faxén-irving et al., Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial, Arch. Neurol, vol.63, pp.1402-1408, 2006.

V. Frisardi, F. Panza, D. Seripa, T. Farooqui, and A. A. Farooqui, Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology, Prog. Lipid Res, vol.50, pp.313-330, 2011.

B. Y. Fu, S. L. Ma, N. L. Tang, C. W. Tam, V. W. Lui et al., Cholesterol 24-hydroxylase (CYP46A1) polymorphisms are associated with faster cognitive deterioration in Chinese older persons: a two-year follow up study, Int J Geriatr Psychiatry, vol.24, pp.921-926, 2009.

M. Fukuda, F. Kanou, N. Shimada, M. Sawabe, Y. Saito et al., Elevated levels of 4-hydroxynonenalhistidine Michael adduct in the hippocampi of patients with Alzheimer's disease, Biomed. Res, vol.30, pp.227-233, 2009.

H. Fukumoto, A. Deng, M. C. Irizarry, M. L. Fitzgerald, and G. W. Rebeck, Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels, J. Biol. Chem, vol.277, pp.48508-48513, 2002.

M. Fumagalli, S. Daniele, D. Lecca, P. R. Lee, C. Parravicini et al., Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation, J. Biol. Chem, vol.286, pp.10593-10604, 2011.

U. Fünfschilling, W. J. Jockusch, N. Sivakumar, W. Möbius, K. Corthals et al., Critical time window of neuronal cholesterol synthesis during neurite outgrowth, J. Neurosci, vol.32, pp.7632-7645, 2012.

D. Games, D. Adams, R. Alessandrini, R. Barbour, P. Berthelette et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein, Nature, vol.373, pp.523-527, 1995.

N. Gamper, O. Zaika, Y. Li, P. Martin, C. C. Hernandez et al., Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing, EMBO J, vol.25, pp.4996-5004, 2006.

L. Gan and L. K. Kaczmarek, When, where, and how much? Expression of the Kv3.1 potassium channel in high-frequency firing neurons, J. Neurobiol, vol.37, pp.69-79, 1998.

F. Gantner, S. Uhlig, W. , and A. , Quinine inhibits release of tumor necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure, Eur. J. Pharmacol, vol.294, pp.353-355, 1995.

D. P. Gaposchkin and R. A. Zoeller, Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line. Insights using ether lipid-deficient variants, J. Lipid Res, vol.40, pp.495-503, 1999.

K. Gawrisch and O. Soubias, Structure and dynamics of polyunsaturated hydrocarbon chains in lipid bilayers-significance for GPCR function, Chem. Phys. Lipids, vol.153, pp.64-75, 2008.

F. Geillon, D. Trompier, C. Gondcaille, G. Lizard, and S. Savary, , 2012.

, Med Sci, vol.28, pp.1087-1094

I. C. Gelissen, M. Harris, K. Rye, C. Quinn, A. J. Brown et al., ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I, Arterioscler. Thromb. Vasc. Biol, vol.26, pp.534-540, 2006.

M. S. Ghandour, A. Feutz, W. Jalabi, O. Taleb, D. Bessert et al., Trafficking of PLP/DM20 and cAMP signaling in immortalized jimpy oligodendrocytes, Glia, vol.40, pp.300-311, 2002.

S. Ghosh and S. K. Khare, Biodegradation of cytotoxic 7-Ketocholesterol by Pseudomonas aeruginosa PseA, Bioresour. Technol, vol.213, pp.44-49, 2016.

W. Gibson-wood, G. P. Eckert, U. Igbavboa, and W. E. Müller, Amyloid betaprotein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease, Biochim. Biophys. Acta, vol.1610, pp.281-290, 2003.

C. R. Giordano and S. R. Terlecky, Peroxisomes, cell senescence, and rates of aging, Biochim. Biophys. Acta, vol.1822, pp.1358-1362, 2012.

J. R. Giudicessi and M. J. Ackerman, Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy, Nat Rev Cardiol, vol.9, pp.319-332, 2012.

G. G. Glenner, J. H. Henry, and S. Fujihara, Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration, Ann Pathol, vol.1, pp.120-129, 1981.

K. Göbel, J. Wedell, A. M. Herrmann, L. Wachsmuth, S. Pankratz et al., 4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis, Exp. Neurol, vol.248, pp.62-71, 2013.

M. Goedert, M. G. Spillantini, R. Jakes, D. Rutherford, and R. A. Crowther, Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease, Neuron, vol.3, pp.519-526, 1989.

D. S. Goldman-wohl, E. Chan, D. Baird, and N. Heintz, Kv3.3b: a novel Shaw type potassium channel expressed in terminally differentiated cerebellar Purkinje cells and deep cerebellar nuclei, J. Neurosci, vol.14, pp.511-522, 1994.

T. Gómez-isla, R. Hollister, H. West, S. Mui, J. H. Growdon et al., Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann. Neurol, vol.41, pp.17-24, 1997.

L. Gong, T. M. Gao, H. Huang, Z. Zhuang, and Z. Tong, Transient forebrain ischemia induces persistent hyperactivity of large conductance Ca2+-activated potassium channels via oxidation modulation in rat hippocampal CA1 pyramidal neurons, Eur. J. Neurosci, vol.15, pp.779-783, 2002.

Y. Gong, L. Chang, K. L. Viola, P. N. Lacor, M. P. Lambert et al., Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.10417-10422, 2003.

F. M. Goñi, A. , and A. , Sphingomyelinases: enzymology and membrane activity, FEBS Lett, vol.531, pp.38-46, 2002.

T. A. Good, D. O. Smith, and R. M. Murphy, Beta-amyloid peptide blocks the fastinactivating K+ current in rat hippocampal neurons, Biophys. J, vol.70, pp.296-304, 1996.

A. D. Goodman, T. R. Brown, L. B. Krupp, R. T. Schapiro, S. R. Schwid et al., , 2009.

, Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial, Lancet, vol.373, pp.732-738

K. Gorgas, A. Teigler, D. Komljenovic, and W. W. Just, The ether lipid-deficient mouse: tracking down plasmalogen functions, Biochim. Biophys. Acta, vol.1763, pp.1511-1526, 2006.

F. Gosselet, P. Candela, E. Sevin, V. Berezowski, R. Cecchelli et al., Transcriptional profiles of receptors and transporters involved in brain cholesterol homeostasis at the blood-brain barrier: use of an in vitro model, Brain Res, vol.1249, pp.34-42, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00543674

R. C. Green, L. A. Cupples, R. Go, K. S. Benke, T. Edeki et al., Risk of dementia among white and African American relatives of patients with Alzheimer disease, JAMA, vol.287, pp.329-336, 2002.

S. Grissmer, B. Dethlefs, J. J. Wasmuth, A. L. Goldin, G. A. Gutman et al., Expression and chromosomal localization of a lymphocyte K+ channel gene, Proc. Natl. Acad. Sci. U.S.A, vol.87, pp.9411-9415, 1990.

E. Grober, C. B. Hall, R. B. Lipton, A. B. Zonderman, S. M. Resnick et al., Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease, J Int Neuropsychol Soc, vol.14, pp.266-278, 2008.

M. Grønn, E. Christensen, T. A. Hagve, and B. O. Christophersen, Peroxisomal retroconversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) studied in isolated rat liver cells, Biochim. Biophys. Acta, vol.1081, pp.85-91, 1991.

M. Grosclaude, Psychothérapies des démences. Quels fondements ? Quels objectifs ? (Montrouge: Editions John Libbey Eurotext), 1997.

I. Grundke-iqbal, K. Iqbal, L. George, Y. C. Tung, K. S. Kim et al., Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease, Proc. Natl. Acad. Sci. U.S.A, vol.86, pp.2853-2857, 1989.

Y. Gu, J. Barry, R. Mcdougel, D. Terman, and C. Gu, Alternative splicing regulates kv3.1 polarized targeting to adjust maximal spiking frequency, J. Biol. Chem, vol.287, pp.1755-1769, 2012.

F. Guardiola, R. Codony, P. B. Addis, M. Rafecas, and J. Boatella, Biological effects of oxysterols: current status, Food Chem. Toxicol, vol.34, pp.193-211, 1996.

T. I. Gudz, T. E. Schneider, T. A. Haas, and W. B. Macklin, Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes, J. Neurosci, vol.22, pp.7398-7407, 2002.

J. B. Gurdon, C. D. Lane, H. R. Woodland, and G. Marbaix, Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells, Nature, vol.233, pp.177-182, 1971.

G. A. Gutman, K. G. Chandy, S. Grissmer, M. Lazdunski, D. Mckinnon et al., International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels, Pharmacol. Rev, vol.57, pp.473-508, 2005.

D. L. Gutteridge, The effect of variations in fibre length on the impact strength of poly(methyl methacrylate) resin reinforced with ultra-high-modulus polyethylene fibre, Clin Mater, vol.12, pp.137-140, 1993.

C. Haass and D. J. Selkoe, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide, Nat. Rev. Mol. Cell Biol, vol.8, pp.101-112, 2007.

H. Haghdoost-yazdi, A. Faraji, N. Fraidouni, M. Movahedi, E. Hadibeygi et al., Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease, Behav. Brain Res, vol.223, pp.70-74, 2011.

J. Haleng, J. Pincemail, J. O. Defraigne, C. Charlier, and J. P. Chapelle, , 2007.

, Rev Med Liege, vol.62, pp.628-638

B. Halliwell, The wanderings of a free radical. Free Radic, Biol. Med, vol.46, pp.531-542, 2009.

A. Hamacher-brady, Autophagy regulation and integration with cell signaling, Antioxid. Redox Signal, vol.17, pp.756-765, 2012.
DOI : 10.1089/ars.2011.4410

N. S. Hamblet, B. Ragland, M. Ali, B. Conyers, and F. J. Castora, Mutations in mitochondrial-encoded cytochrome c oxidase subunits I, II, and III genes detected in, 2006.

M. Igarashi, K. Ma, F. Gao, H. Kim, S. I. Rapoport et al., Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex, J. Alzheimers Dis, vol.24, pp.507-517, 2011.

E. Y. Isacoff, Y. N. Jan, J. , and L. Y. , Putative receptor for the cytoplasmic inactivation gate in the Shaker K+ channel, Nature, vol.353, pp.86-90, 1991.

K. Ishikawa, M. Tanaka, J. A. Black, and S. G. Waxman, Changes in expression of voltage-gated potassium channels in dorsal root ganglion neurons following axotomy, Muscle Nerve, vol.22, pp.502-507, 1999.

S. Itagaki, P. L. Mcgeer, H. Akiyama, S. Zhu, and D. Selkoe, Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease, J. Neuroimmunol, vol.24, pp.173-182, 1989.

T. Iwatsubo, A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina et al., Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43), Neuron, vol.13, pp.45-53, 1994.

O. Jahn, S. Tenzer, and H. B. Werner, Myelin proteomics: molecular anatomy of an insulating sheath, Mol. Neurobiol, vol.40, pp.55-72, 2009.

R. Jakob and J. Krieglstein, Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones, Br. J. Pharmacol, vol.122, pp.1333-1338, 1997.

B. A. Janowski, The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.12675-12680, 2002.

N. Jantaratnotai, J. K. Ryu, S. U. Kim, and J. G. Mclarnon, Amyloid beta peptideinduced corpus callosum damage and glial activation in vivo, Neuroreport, vol.14, pp.1429-1433, 2003.

N. B. Javitt and J. C. Javitt, The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration, Curr Opin Ophthalmol, vol.20, pp.151-157, 2009.

X. Jiang, R. Sidhu, F. D. Porter, N. M. Yanjanin, A. O. Speak et al., A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma, J. Lipid Res, vol.52, pp.1435-1445, 2011.

C. Joffre, L. Leclère, B. Buteau, L. Martine, S. Cabaret et al., Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells, Curr. Eye Res, vol.32, pp.271-280, 2007.

R. C. Johnson and S. N. Shah, Cholesterol ester metabolizing enzymes in human brain: properties, subcellular distribution and relative levels in various diseased conditions, J. Neurochem, vol.31, pp.895-902, 1978.

S. B. Joseph, E. Mckilligin, L. Pei, M. A. Watson, A. R. Collins et al., Synthetic LXR ligand inhibits the development of atherosclerosis in mice, Proc. Natl. Acad. Sci. U.S.A, vol.99, pp.7604-7609, 2002.

G. Jun, A. C. Naj, G. W. Beecham, L. Wang, J. Buros et al., Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes, Arch. Neurol, vol.67, pp.1473-1484, 2010.

M. Jung, I. Sommer, M. Schachner, and K. A. Nave, Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice, J. Neurosci, vol.16, pp.7920-7929, 1996.

A. Kaasik, T. Rikk, A. Piirsoo, T. Zharkovsky, and A. Zharkovsky, Up-regulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium, Eur. J. Neurosci, vol.22, pp.1023-1031, 2005.

P. Katsel, C. Li, and V. Haroutunian, Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?, Neurochem. Res, vol.32, pp.845-856, 2007.

S. Kemp and R. Wanders, Biochemical aspects of X-linked adrenoleukodystrophy, Brain Pathol, vol.20, pp.831-837, 2010.

M. Kempf, A. Clement, A. Faissner, G. Lee, and R. Brandt, Tau binds to the distal axon early in development of polarity in a microtubule-and microfilamentdependent manner, J. Neurosci, vol.16, pp.5583-5592, 1996.

H. Kettenmann and M. Schachner, Pharmacological properties of gammaaminobutyric acid-, glutamate-, and aspartate-induced depolarizations in cultured astrocytes, J. Neurosci, vol.5, pp.3295-3301, 1985.

H. Kettenmann, R. Banati, and W. Walz, Electrophysiological behavior of microglia, Glia, vol.7, pp.93-101, 1993.

H. Kettenmann, F. Kirchhoff, and A. Verkhratsky, Microglia: new roles for the synaptic stripper, Neuron, vol.77, pp.10-18, 2013.

S. A. Khalifa, P. De-medina, A. Erlandsson, H. R. El-seedi, S. Silvente-poirot et al., The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells, Biochem. Biophys. Res. Commun, vol.446, pp.681-686, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00968932

R. Khanna, L. Roy, X. Zhu, and L. C. Schlichter, K+ channels and the microglial respiratory burst, Am. J. Physiol, vol.280, pp.796-806, 2001.

K. Kikuchi, K. Sakai, T. Suzuki, and K. Takama, Fatty acid composition of choline and ethanolamine glycerophospholipid subclasses in heart tissue of mammals and migratory and demersal fish, Comp. Biochem. Physiol. B, Biochem. Mol. Biol, vol.124, pp.271-283, 1999.

A. Kowalska, Genetic basis of neurodegeneration in familial Alzheimer's disease, Pol J Pharmacol, vol.56, pp.171-178, 2004.

M. L. Kraybill, E. B. Larson, D. W. Tsuang, L. Teri, W. C. Mccormick et al., Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both, Neurology, vol.64, pp.2069-2073, 2005.

G. W. Kreutzberg, Microglia: a sensor for pathological events in the CNS, Trends Neurosci, vol.19, pp.312-318, 1996.

B. Kuczynski and N. V. Reo, Evidence that plasmalogen is protective against oxidative stress in the rat brain, Neurochem. Res, vol.31, pp.639-656, 2006.

F. M. Laferla and S. Oddo, Alzheimer's disease: Abeta, tau and synaptic dysfunction, Trends Mol Med, vol.11, pp.170-176, 2005.

M. P. Lambert, A. K. Barlow, B. A. Chromy, C. Edwards, R. Freed et al., Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.6448-6453, 1998.

P. A. Lang, S. Kaiser, S. Myssina, T. Wieder, F. Lang et al., Role of Ca2+-activated K+ channels in human erythrocyte apoptosis, Am. J. Physiol, vol.285, pp.1553-1560, 2003.

M. Langner and S. W. Hui, Merocyanine interaction with phosphatidylcholine bilayers, Biochim. Biophys. Acta, vol.1149, pp.175-179, 1993.

J. M. Langosch, P. J. Gebicke-haerter, W. Nörenberg, and P. Illes, Characterization and transduction mechanisms of purinoceptors in activated rat microglia, Br. J. Pharmacol, vol.113, pp.29-34, 1994.

C. M. Lauderback, J. M. Hackett, F. F. Huang, J. N. Keller, L. I. Szweda et al., The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42, J. Neurochem, vol.78, pp.413-416, 2001.

I. Lauritzen, J. R. De-weille, and M. Lazdunski, The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons, J. Neurochem, vol.69, pp.1570-1579, 1997.

P. B. Lazarow and C. De-duve, A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug, Proc. Natl. Acad. Sci. U.S.A, vol.73, pp.2043-2046, 1976.

D. Lecca, M. L. Trincavelli, P. Gelosa, L. Sironi, P. Ciana et al., The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair, PLoS ONE, vol.3, p.3579, 2008.

A. G. Lee, How lipids affect the activities of integral membrane proteins, Biochim. Biophys. Acta, vol.1666, pp.62-87, 2004.

J. Y. Lee and D. H. Hwang, Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line, Biochem. Biophys. Res. Commun, vol.298, pp.667-674, 2002.

S. Lee, B. Yoon, K. Berglund, S. Oh, H. Park et al., Channel-mediated tonic GABA release from glia, Science, vol.330, pp.790-796, 2010.

M. Lemeignan, H. Millart, D. Lamiable, J. Molgo, and P. Lechat, Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats, Brain Res, vol.304, pp.166-169, 1984.

V. Leoni, Oxysterols as markers of neurological disease--a review, Scand. J. Clin. Lab. Invest, vol.69, pp.22-25, 2009.

V. Leoni and C. Caccia, Oxysterols as biomarkers in neurodegenerative diseases, Chem. Phys. Lipids, vol.164, pp.515-524, 2011.

V. Leoni and C. Caccia, 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases, Biochimie, vol.95, pp.595-612, 2013.

V. Leoni and C. Caccia, Study of cholesterol metabolism in Huntington's disease, Biochem. Biophys. Res. Commun, vol.446, pp.697-701, 2014.

V. Leoni, D. Lütjohann, and T. Masterman, Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis, J. Lipid Res, vol.46, pp.191-195, 2005.

V. Leoni, T. Nury, A. Vejux, A. Zarrouk, C. Caccia et al., Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with ?-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors, J. Steroid Biochem. Mol. Biol, vol.169, pp.96-110, 2017.

F. Lesage, I. Lauritzen, F. Duprat, R. Reyes, M. Fink et al., The structure, function and distribution of the mouse TWIK-1 K+ channel, FEBS Lett, vol.402, pp.28-32, 1997.

G. Leung, W. Sun, L. Zheng, S. Brookes, M. Tully et al., Anti-acrolein treatment improves behavioral outcome and alleviates myelin damage in experimental autoimmune encephalomyelitis mouse, Neuroscience, vol.173, pp.150-155, 2011.

T. Levade, S. Malagarie-cazenave, V. Gouazé, B. Ségui, C. Tardy et al., Ceramide in apoptosis: a revisited role, Neurochem. Res, vol.27, pp.601-607, 2002.

R. L. Levine, Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic, Biol. Med, vol.32, pp.790-796, 2002.

Y. Liu and D. D. Gutterman, Oxidative stress and potassium channel function, Clin. Exp. Pharmacol. Physiol, vol.29, pp.305-311, 2002.

G. Lizard, S. Monier, C. Cordelet, L. Gesquière, V. Deckert et al., Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall, Arterioscler. Thromb. Vasc. Biol, vol.19, pp.1190-1200, 1999.

G. Lizard, S. Monier, C. Cordelet, L. Gesquière, V. Deckert et al., Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall, Arterioscler. Thromb. Vasc. Biol, vol.19, pp.1190-1200, 1999.

G. Lizard, S. Monier, C. Cordelet, L. Gesquière, V. Deckert et al., Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall, Arterioscler. Thromb. Vasc. Biol, vol.19, pp.1190-1200, 1999.

G. Lizard, P. Roignot, M. Maynadie, S. Lizard-nacol, M. F. Poupon et al., Flow cytometry evaluation of the multidrug-resistant phenotype with functional tests involving uptake of daunorubicin, Hoechst 33342, or rhodamine 123: a comparative study, Cancer Detect. Prev, vol.19, pp.527-534, 1995.

G. Lizard, O. Rouaud, J. Demarquoy, M. Cherkaoui-malki, and L. Iuliano, Potential roles of peroxisomes in Alzheimer's disease and in dementia of the Alzheimer's type, J. Alzheimers Dis, vol.29, pp.241-254, 2012.

T. Lømo, The discovery of long-term potentiation, Philos. Trans. R. Soc. Lond., B, Biol. Sci, vol.358, pp.617-620, 2003.

M. A. Lovell, S. P. Gabbita, and W. R. Markesbery, Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF, J. Neurochem, vol.72, pp.771-776, 1999.

E. Lund, I. Björkhem, C. Furster, and K. Wikvall, 24-, 25-and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver, Biochim. Biophys. Acta, vol.1166, pp.177-182, 1993.

E. G. Lund, J. M. Guileyardo, and D. W. Russell, cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain, Proc. Natl. Acad. Sci. U.S.A, vol.96, pp.7238-7243, 1999.

E. G. Lund, J. G. Menke, and C. P. Sparrow, Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis, Arterioscler. Thromb. Vasc. Biol, vol.23, pp.1169-1177, 2003.

C. J. Luneau, J. B. Williams, J. Marshall, E. S. Levitan, C. Oliva et al., Alternative splicing contributes to K+ channel diversity in the mammalian central nervous system, Proc, 1991.

, Natl. Acad. Sci. U.S.A, vol.88, pp.3932-3936

J. W. Lustbader, M. Cirilli, C. Lin, H. W. Xu, K. Takuma et al., ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease, Science, vol.304, pp.448-452, 2004.

D. Lütjohann, O. Breuer, G. Ahlborg, I. Nennesmo, A. Sidén et al., Cholesterol homeostasis in human brain: evidence for an agedependent flux of 24S-hydroxycholesterol from the brain into the circulation, Proc. Natl. Acad. Sci. U.S.A, vol.93, pp.9799-9804, 1996.

D. Lütjohann, A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli et al., Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients, J. Lipid Res, vol.41, pp.195-198, 2000.

B. Luu, , 1995.

C. R. , Seances Soc. Biol. Fil, vol.189, pp.827-837

R. Maeba and N. Ueta, Ethanolamine plasmalogen and cholesterol reduce the total membrane oxidizability measured by the oxygen uptake method, Biochem. Biophys. Res. Commun, vol.302, pp.265-270, 2003.

P. J. Magistretti, Neuron-glia metabolic coupling and plasticity, Exp. Physiol, vol.96, pp.407-410, 2011.

P. Maher, Redox control of neural function: background, mechanisms, and significance, Antioxid. Redox Signal, vol.8, pp.1941-1970, 2006.

R. W. Mahley, Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism, Arterioscler. Thromb. Vasc. Biol, vol.36, pp.1305-1315, 2016.

S. Maioli, A. Båvner, Z. Ali, M. Heverin, M. Ismail et al., Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?, PLoS ONE, vol.8, p.68534, 2013.

S. A. Malin, W. X. Guo, G. Jafari, A. M. Goate, and J. M. Nerbonne, Presenilins upregulate functional K+ channel currents in mammalian cells, Neurobiol. Dis, vol.4, pp.398-409, 1998.

S. Mandrekar-colucci and G. E. Landreth, Nuclear receptors as therapeutic targets for Alzheimer's disease, Expert Opin. Ther. Targets, vol.15, pp.1085-1097, 2011.

T. I. Mandybur and C. C. Chuirazzi, Astrocytes and the plaques of Alzheimer's disease, Neurology, vol.40, pp.635-639, 1990.

N. Marchesini and Y. A. Hannun, Acid and neutral sphingomyelinases: roles and mechanisms of regulation, Biochem. Cell Biol, vol.82, pp.27-44, 2004.

J. L. Marín-teva, I. Dusart, C. Colin, A. Gervais, N. Van-rooijen et al., Microglia promote the death of developing Purkinje cells, Neuron, vol.41, pp.535-547, 2004.

L. Marner, J. R. Nyengaard, Y. Tang, and B. Pakkenberg, Marked loss of myelinated nerve fibers in the human brain with age, J. Comp. Neurol, vol.462, pp.144-152, 2003.

L. J. Marnett, Lipid peroxidation-DNA damage by malondialdehyde, Mutat. Res, vol.424, pp.83-95, 1999.

L. J. Marnett, Oxyradicals and DNA damage, Carcinogenesis, vol.21, pp.361-370, 2000.

F. Marques, J. C. Sousa, N. Sousa, and J. A. Palha, Blood-brain-barriers in aging and in Alzheimer's disease, Mol Neurodegener, vol.8, p.38, 2013.

S. E. Marsh, B. , and M. , Examining the mechanisms that link ?-amyloid and ?-synuclein pathologies, Alzheimers Res Ther, vol.4, p.11, 2012.

W. Martinet, M. De-bie, D. M. Schrijvers, G. R. De-meyer, A. G. Herman et al., 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light chain 3 processing in vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol, vol.24, pp.2296-2301, 2004.

E. Masliah, R. D. Terry, M. Mallory, M. Alford, and L. A. Hansen, Diffuse plaques do not accentuate synapse loss in Alzheimer's disease, Am. J. Pathol, vol.137, pp.1293-1297, 1990.

S. Matalon, K. M. Hardiman, L. Jain, D. C. Eaton, M. Kotlikoff et al., Regulation of ion channel structure and function by reactive oxygen-nitrogen species, Am. J. Physiol. Lung Cell Mol. Physiol, vol.285, pp.1184-1189, 2003.

J. M. Matés, J. M. Segura, C. Pérez-gómez, R. Rosado, L. Olalla et al., Antioxidant enzymatic activities in human blood cells after an allergic reaction to pollen or house dust mite, Blood Cells Mol. Dis, vol.25, pp.103-109, 1999.

M. P. Mattson, R. G. Cutler, J. , and D. , Alzheimer peptides perturb lipid-regulating enzymes, Nat. Cell Biol, vol.7, pp.1045-1047, 2005.

N. Mattsson, M. C. Carrillo, R. A. Dean, M. D. Devous, T. Nikolcheva et al., Revolutionizing Alzheimer's disease and clinical trials through biomarkers, Alzheimers Dement (Amst), vol.1, pp.412-419, 2015.

N. Mattsson, P. S. Insel, R. Nosheny, D. Tosun, J. Q. Trojanowski et al., Emerging ?-amyloid pathology and accelerated cortical atrophy, JAMA Neurol, vol.71, pp.725-734, 2014.

D. H. Mauch, K. Nägler, S. Schumacher, C. Göritz, E. C. Müller et al., CNS synaptogenesis promoted by glia-derived cholesterol, Science, vol.294, pp.1354-1357, 2001.

I. Maurer, S. Zierz, and H. J. Möller, A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients, Neurobiol. Aging, vol.21, pp.455-462, 2000.

R. Mayeux, Clinical practice. Early Alzheimer's disease, N. Engl. J. Med, vol.362, pp.2194-2201, 2010.

M. Mazzuca and F. Lesage, , 2007.

, Rev Med Interne, vol.28, pp.576-579

L. Mcevoy, R. A. Schlegel, P. Williamson, D. Buono, and B. J. , Merocyanine 540 as a flow cytometric probe of membrane lipid organization in leukocytes, J. Leukoc. Biol, vol.44, pp.337-344, 1988.

P. L. Mcgeer, H. Akiyama, T. Kawamata, T. Yamada, D. G. Walker et al., Immunohistochemical localization of beta-amyloid precursor protein sequences in Alzheimer and normal brain tissue by light and electron microscopy, J. Neurosci. Res, vol.31, pp.428-442, 1992.

E. Mcgowan, J. Eriksen, and M. Hutton, A decade of modeling Alzheimer's disease in transgenic mice, Trends Genet, vol.22, pp.281-289, 2006.

G. Mckhann, D. Drachman, M. Folstein, R. Katzman, D. Price et al., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, vol.34, pp.939-944, 1984.

C. A. Mclean, R. A. Cherny, F. W. Fraser, S. J. Fuller, M. J. Smith et al., Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol, vol.46, pp.860-866, 1999.

R. K. Mcnamara and S. E. Carlson, Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology, Prostaglandins Leukot. Essent. Fatty Acids, vol.75, pp.329-349, 2006.

N. Medeiros, L. Dai, and A. V. Ferguson, Glucose-responsive neurons in the subfornical organ of the rat--a novel site for direct CNS monitoring of circulating glucose, Neuroscience, vol.201, pp.157-165, 2012.

J. H. Medina and I. Izquierdo, Retrograde messengers, long-term potentiation and memory, Brain Res. Brain Res. Rev, vol.21, pp.185-194, 1995.

W. Meier-ruge, J. Ulrich, M. Brühlmann, and E. Meier, Age-related white matter atrophy in the human brain, Ann. N. Y. Acad. Sci, vol.673, pp.260-269, 1992.

W. J. Meilandt, G. Yu, J. Chin, E. D. Roberson, J. J. Palop et al., Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease, J. Neurosci, vol.28, pp.5007-5017, 2008.

E. A. Mellon, D. T. Pilkinton, C. M. Clark, M. A. Elliott, W. R. Witschey et al., Sodium MR imaging detection of mild Alzheimer disease: preliminary study, AJNR Am J Neuroradiol, vol.30, pp.978-984, 2009.

B. Menn, J. M. Garcia-verdugo, C. Yaschine, O. Gonzalez-perez, D. Rowitch et al., Origin of oligodendrocytes in the subventricular zone of the adult brain, J. Neurosci, vol.26, pp.7907-7918, 2006.

J. C. Middlebrooks, H. S. Nick, S. H. Subramony, J. Advincula, R. L. Rosales et al., Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms, PLoS ONE, vol.8, p.76749, 2013.

M. M. Mielke and N. J. Haughey, Could plasma sphingolipids be diagnostic or prognostic biomarkers for Alzheimer's disease?, Clin Lipidol, vol.7, pp.525-536, 2012.

L. Migliore, I. Fontana, R. Colognato, F. Coppede, G. Siciliano et al., Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases, Neurobiol. Aging, vol.26, pp.587-595, 2005.

T. Miki, F. Tashiro, T. Iwanaga, K. Nagashima, H. Yoshitomi et al., Abnormalities of pancreatic islets by targeted expression of a dominant-negative KATP channel, Proc. Natl. Acad. Sci. U.S.A, vol.94, pp.11969-11973, 1997.

C. Miller, An overview of the potassium channel family, Genome Biol, vol.1, p.4, 2000.

J. A. Miller, R. L. Woltjer, J. M. Goodenbour, S. Horvath, and D. H. Geschwind, Genes and pathways underlying regional and cell type changes in Alzheimer's disease, Genome Med, vol.5, p.48, 2013.

J. C. Molenaar, From the library of the Netherlands Journal of Medicine. Rudolf Virchow: Die Cellularpathologie in ihrer Begründung auf physiologische und pathologische Gewebelehre, vol.1858, 2003.

, Ned Tijdschr Geneeskd, vol.147, pp.2236-2244

I. M. Møller, A. Rogowska-wrzesinska, and R. S. Rao, Protein carbonylation and metal-catalyzed protein oxidation in a cellular perspective, J Proteomics, vol.74, pp.2228-2242, 2011.

K. S. Montine, P. J. Kim, S. J. Olson, W. R. Markesbery, and T. J. Montine, 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease, J. Neuropathol. Exp. Neurol, vol.56, pp.866-871, 1997.

T. J. Montine, W. R. Markesbery, W. Zackert, S. C. Sanchez, L. J. Roberts et al., The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients, Am. J. Pathol, vol.155, pp.863-868, 1999.

K. J. Moore, J. Khoury, L. A. Medeiros, K. Terada, C. Geula et al., A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid, J. Biol. Chem, vol.277, pp.47373-47379, 2002.

C. Morgan, M. Colombres, M. T. Nuñez, and N. C. Inestrosa, Structure and function of amyloid in Alzheimer's disease, Prog. Neurobiol, vol.74, pp.323-349, 2004.

M. Mórocz, J. Kálmán, A. Juhász, I. Sinkó, A. P. Mcglynn et al., Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease, Neurobiol. Aging, vol.23, pp.47-53, 2002.

M. C. Morris and C. C. Tangney, Dietary fat composition and dementia risk, Neurobiol. Aging, vol.35, issue.2, pp.59-64, 2014.

R. G. Morris, P. Garrud, J. N. Rawlins, and J. Keefe, Place navigation impaired in rats with hippocampal lesions, Nature, vol.297, pp.681-683, 1982.

J. P. Mothet, A. T. Parent, H. Wolosker, R. O. Brady, D. J. Linden et al., D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.4926-4931, 2000.

P. N. Moynagh, The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain, J. Anat, vol.207, pp.265-269, 2005.

L. Mucke, E. Masliah, G. Q. Yu, M. Mallory, E. M. Rockenstein et al., High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J. Neurosci, vol.20, pp.4050-4058, 2000.

S. Mukherjee, X. Zha, I. Tabas, and F. R. Maxfield, Cholesterol distribution in living cells: fluorescence imaging using dehydroergosterol as a fluorescent cholesterol analog, Biophys. J, vol.75, pp.1915-1925, 1998.

T. Mura, J. Dartigues, and C. Berr, How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050, Eur. J. Neurol, vol.17, pp.252-259, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00426844

V. Mutemberezi, O. Guillemot-legris, and G. G. Muccioli, Oxysterols: From cholesterol metabolites to key mediators, Prog. Lipid Res, vol.64, pp.152-169, 2016.

A. Mutka, S. Lusa, M. D. Linder, E. Jokitalo, O. Kopra et al., Secretion of sterols and the NPC2 protein from primary astrocytes, J. Biol. Chem, vol.279, pp.48654-48662, 2004.

Z. Nackerdien, G. Rao, M. A. Cacciuttolo, E. Gajewski, and M. Dizdaroglu, Chemical nature of DNA-protein cross-links produced in mammalian chromatin by hydrogen peroxide in the presence of iron or copper ions, Biochemistry, vol.30, pp.4873-4879, 1991.

N. Nagan and R. A. Zoeller, Plasmalogens: biosynthesis and functions, Prog. Lipid Res, vol.40, pp.199-229, 2001.

R. G. Nagele, M. R. D'andrea, H. Lee, V. Venkataraman, and H. Wang, Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains, Brain Res, vol.971, pp.197-209, 2003.

K. Nave, Myelination and support of axonal integrity by glia, Nature, vol.468, pp.244-252, 2010.

A. R. Neill and C. J. Masters, Metabolism of fatty acids by ovine spermatozoa, J. Reprod. Fertil, vol.34, pp.279-287, 1973.

J. A. Nelson, S. R. Steckbeck, and T. A. Spencer, Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide, J. Biol. Chem, vol.256, pp.1067-1068, 1981.

H. M. Nielsen, D. Ek, U. Avdic, C. Orbjörn, O. Hansson et al., NG2 cells, a new trail for Alzheimer's disease mechanisms?, Acta Neuropathol Commun, vol.1, p.7, 2013.

A. Nimmerjahn, F. Kirchhoff, and F. Helmchen, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, vol.308, pp.1314-1318, 2005.

N. Noguchi, Y. Saito, and Y. Urano, Diverse functions of 24(S)-hydroxycholesterol in the brain, Biochem. Biophys. Res. Commun, vol.446, pp.692-696, 2014.

N. Noguchi, Y. Urano, W. Takabe, and Y. Saito, New aspects of 24(S)-hydroxycholesterol in modulating neuronal cell death. Free Radic, Biol. Med, vol.87, pp.366-372, 2015.

W. Nörenberg, K. Appel, J. Bauer, P. J. Gebicke-haerter, and P. Illes, Expression of an outwardly rectifying K+ channel in rat microglia cultivated on teflon, Neurosci. Lett, vol.160, pp.69-72, 1993.

J. Nourooz-zadeh, E. H. Liu, B. Yhlen, E. E. Anggård, and B. Halliwell, F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease, J. Neurochem, vol.72, pp.734-740, 1999.

M. T. Nunez and J. Glass, Reconstitution of the transferrin receptor in lipid vesicles. Effect of cholesterol on the binding of transferrin, Biochemistry, vol.21, pp.4139-4143, 1982.

T. Nury, A. Zarrouk, J. J. Mackrill, M. Samadi, P. Durand et al., Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7?-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of ?-tocopherol and docosahexaenoic acid, Steroids, vol.99, pp.194-203, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01518110

T. Nury, A. Zarrouk, K. Ragot, M. Debbabi, J. Riedinger et al., 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: Potential roles of 7-ketocholesterol in the pathophysiology of X-ALD, J. Steroid Biochem. Mol. Biol, vol.169, pp.123-136, 2017.

N. A. Oberheim, X. Wang, S. Goldman, and M. Nedergaard, Astrocytic complexity distinguishes the human brain, Trends Neurosci, vol.29, pp.547-553, 2006.

S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde et al., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction, Neuron, vol.39, pp.409-421, 2003.

T. Ogishima, S. Deguchi, and K. Okuda, Purification and characterization of, 1987.

L. Packer, Oxidants, antioxidant nutrients and the athlete, J Sports Sci, vol.15, pp.353-363, 1997.
DOI : 10.1080/026404197367362

S. Pal, K. A. Hartnett, J. M. Nerbonne, E. S. Levitan, A. et al., Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels, J. Neurosci, vol.23, pp.4798-4802, 2003.

S. Pal, K. He, A. , and E. , Nitrosative stress and potassium channel-mediated neuronal apoptosis: is zinc the link?, Pflugers Arch, vol.448, pp.296-303, 2004.

R. Pamplona, M. Portero-otín, C. Ruiz, R. Gredilla, A. Herrero et al., Double bond content of phospholipids and lipid peroxidation negatively correlate with maximum longevity in the heart of mammals, Mech. Ageing Dev, vol.112, pp.169-183, 2000.

A. Pannaccione, F. Boscia, A. Scorziello, A. Adornetto, P. Castaldo et al., Up-regulation and increased activity of KV3.4 channels and their accessory subunit MinK-related peptide 2 induced by amyloid peptide are involved in apoptotic neuronal death, Mol. Pharmacol, vol.72, pp.665-673, 2007.

U. Panzenboeck, Z. Balazs, A. Sovic, A. Hrzenjak, S. Levak-frank et al., ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells, J. Biol. Chem, vol.277, pp.42781-42789, 2002.

R. C. Paolicelli, G. Bolasco, F. Pagani, L. Maggi, M. Scianni et al., Synaptic pruning by microglia is necessary for normal brain development, Science, vol.333, pp.1456-1458, 2011.

A. Papassotiropoulos, D. Lütjohann, M. Bagli, S. Locatelli, F. Jessen et al., Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease, Neuroreport, vol.11, pp.1959-1962, 2000.

S. Parameshwaran-iyer, C. E. Carr, and T. M. Perney, Localization of KCNC1 (Kv3.1) potassium channel subunits in the avian auditory nucleus magnocellularis and nucleus laminaris during development, J. Neurobiol, vol.55, pp.165-178, 2003.

V. Parpura, T. A. Basarsky, F. Liu, K. Jeftinija, S. Jeftinija et al., , 1994.

, Glutamate-mediated astrocyte-neuron signalling, Nature, vol.369, pp.744-747

A. J. Patel and M. Lazdunski, The 2P-domain K+ channels: role in apoptosis and tumorigenesis, Pflugers Arch, vol.448, pp.261-273, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00091466

R. P. Patel, U. Diczfalusy, S. Dzeletovic, M. T. Wilson, and V. M. Darley-usmar, Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper, J. Lipid Res, vol.37, pp.2361-2371, 1996.

S. M. Paul, J. J. Doherty, A. J. Robichaud, G. M. Belfort, B. Y. Chow et al., The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors, J. Neurosci, vol.33, pp.17290-17300, 2013.

E. Pedruzzi, C. Guichard, V. Ollivier, F. Driss, M. Fay et al., NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells, Mol. Cell. Biol, vol.24, pp.10703-10717, 2004.

L. Pellerin, Food for thought: the importance of glucose and other energy substrates for sustaining brain function under varying levels of activity, Diabetes Metab, p.36, 2010.

D. P. Pelvig, H. Pakkenberg, A. K. Stark, and B. Pakkenberg, Neocortical glial cell numbers in human brains, Neurobiol. Aging, vol.29, pp.1754-1762, 2008.

J. Peng, G. L. Jones, and K. Watson, Stress proteins as biomarkers of oxidative stress: effects of antioxidant supplements. Free Radic, Biol. Med, vol.28, pp.1598-1606, 2000.

M. Perez-neut, L. Haar, V. Rao, S. Santha, K. Lansu et al., Activation of hERG3 channel stimulates autophagy and promotes cellular senescence in melanoma, Oncotarget, vol.7, pp.21991-22004, 2016.

T. M. Perney and L. K. Kaczmarek, Localization of a high threshold potassium channel in the rat cochlear nucleus, J. Comp. Neurol, vol.386, pp.178-202, 1997.

T. M. Perney, J. Marshall, K. A. Martin, S. Hockfield, and L. K. Kaczmarek, Expression of the mRNAs for the Kv3.1 potassium channel gene in the adult and developing rat brain, J. Neurophysiol, vol.68, pp.756-766, 1992.

E. K. Perry, R. H. Perry, B. E. Tomlinson, G. Blessed, and P. H. Gibson, Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic -compartment? of pyruvate dehydrogenase, Neurosci. Lett, vol.18, pp.105-110, 1980.

A. Peters, OBSERVATIONS ON THE CONNEXIONS BETWEEN MYELIN SHEATHS AND GLIAL CELLS IN THE OPTIC NERVES OF YOUNG RATS, J. Anat, vol.98, pp.125-134, 1964.

R. C. Petersen, R. Doody, A. Kurz, R. C. Mohs, J. C. Morris et al., Current concepts in mild cognitive impairment, Arch. Neurol, vol.58, pp.1985-1992, 2001.

G. C. Petzold and V. N. Murthy, Role of astrocytes in neurovascular coupling, Neuron, vol.71, pp.782-797, 2011.

F. W. Pfrieger, Cholesterol homeostasis and function in neurons of the central nervous system, Cell. Mol. Life Sci, vol.60, pp.1158-1171, 2003.

H. T. Phan, T. Hata, M. Morita, T. Yoda, T. Hamada et al., The effect of oxysterols on the interaction of Alzheimer's amyloid beta with model membranes, Biochim. Biophys. Acta, vol.1828, pp.2487-2495, 2013.

R. Pihlaja, J. Koistinaho, T. Malm, H. Sikkilä, S. Vainio et al., Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease, Glia, vol.56, pp.154-163, 2008.

M. J. Pinter, R. F. Waldeck, T. C. Cope, and L. C. Cork, Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease, J. Neurosci, vol.17, pp.4500-4507, 1997.

J. Platas, M. I. Guillén, M. D. Del-caz, F. Gomar, V. Mirabet et al., Conditioned media from adipose-tissue-derived mesenchymal stem cells downregulate degradative mediators induced by interleukin-1? in osteoarthritic chondrocytes, Mediators Inflamm, p.357014, 2013.

J. M. Pocock and H. Kettenmann, Neurotransmitter receptors on microglia, Trends Neurosci, vol.30, pp.527-535, 2007.

E. Polazzi and B. Monti, Microglia and neuroprotection: from in vitro studies to therapeutic applications, Prog. Neurobiol, vol.92, pp.293-315, 2010.

M. C. Polidori, W. Stahl, O. Eichler, I. Niestroj, and H. Sies, Profiles of antioxidants in human plasma. Free Radic, Biol. Med, vol.30, pp.456-462, 2001.

P. Poorkaj, V. Sharma, L. Anderson, E. Nemens, M. E. Alonso et al., Missense mutations in the chromosome 14 familial Alzheimer's disease presenilin 1 gene, Hum. Mutat, vol.11, pp.216-221, 1998.

C. Poulopoulou, I. Markakis, P. Davaki, E. Tsaltas, A. Rombos et al., Aberrant modulation of a delayed rectifier potassium channel by glutamate in Alzheimer's disease, Neurobiol. Dis, vol.37, pp.339-348, 2010.

J. M. Powers and H. W. Moser, Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis, Brain Pathol, vol.8, pp.101-120, 1998.

J. R. Prasanthi, A. Huls, S. Thomasson, A. Thompson, E. Schommer et al., Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells, Mol Neurodegener, vol.4, p.1, 2009.

J. H. Prehn, J. Jordán, G. D. Ghadge, E. Preis, M. F. Galindo et al., Ca2+ and reactive oxygen species in staurosporine-induced neuronal apoptosis, J. Neurochem, vol.68, pp.1679-1685, 1997.

J. Priller, C. A. Haas, M. Reddington, and G. W. Kreutzberg, Calcitonin gene-related peptide and ATP induce immediate early gene expression in cultured rat microglial cells, Glia, vol.15, pp.447-457, 1995.

M. Prinz and J. Priller, Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease, Nat. Rev. Neurosci, vol.15, pp.300-312, 2014.

C. Prunet, S. Lemaire-ewing, F. Ménétrier, D. Néel, and G. Lizard, Activation of caspase-3-dependent and -independent pathways during 7-ketocholesterol-and 7beta-hydroxycholesterol-induced cell death: a morphological and biochemical study, J. Biochem. Mol. Toxicol, vol.19, pp.311-326, 2005.

X. Qiu, Y. Chen, and M. Zhou, Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease, Brain Res, vol.893, pp.261-263, 2001.

Y. G. Qiu, Y. Z. Shen, Z. J. Huang, B. C. Zhao, C. F. He et al., , 2001.

, Yi Chuan Xue Bao, vol.28, pp.166-170

H. W. Querfurth and F. M. Laferla, Alzheimer's disease, N. Engl. J. Med, vol.362, pp.329-344, 2010.

L. A. Rabin, N. Paré, A. J. Saykin, M. J. Brown, H. A. Wishart et al., Differential memory test sensitivity for diagnosing amnestic mild cognitive impairment and predicting conversion to Alzheimer's disease, Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, vol.16, pp.357-376, 2009.

K. Ragot, D. Delmas, A. Athias, T. Nury, M. Baarine et al., ?-Tocopherol impairs 7-ketocholesterol-induced caspase-3-dependent apoptosis involving GSK-3 activation and Mcl-1 degradation on 158N murine oligodendrocytes, Chem. Phys. Lipids, vol.164, pp.469-478, 2011.

K. Ragot, J. J. Mackrill, A. Zarrouk, T. Nury, V. Aires et al., Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes, Biochem. Pharmacol, vol.86, pp.67-79, 2013.

G. Raivich, Like cops on the beat: the active role of resting microglia, Trends Neurosci, vol.28, pp.571-573, 2005.

N. Ramakrishnan, D. E. Mcclain, and G. N. Catravas, Membranes as sensitive targets in thymocyte apoptosis, Int. J. Radiat. Biol, vol.63, pp.693-701, 1993.

I. M. Raman and B. P. Bean, Ionic currents underlying spontaneous action potentials in isolated cerebellar Purkinje neurons, J. Neurosci, vol.19, pp.1663-1674, 1999.

H. Ramaroson, C. Helmer, P. Barberger-gateau, L. Letenneur, J. Dartigues et al., Prevalence of dementia and Alzheimer's disease among subjects aged 75 years or over: updated results of the PAQUID cohort, Rev. Neurol, vol.159, pp.405-411, 2003.

S. Rangaraju, M. Gearing, L. Jin, and A. Levey, Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease, J. Alzheimers Dis, vol.44, pp.797-808, 2015.

R. M. Ransohoff and A. E. Cardona, The myeloid cells of the central nervous system parenchyma, Nature, vol.468, pp.253-262, 2010.

A. V. Rao and B. Balachandran, Role of oxidative stress and antioxidants in neurodegenerative diseases, Nutr Neurosci, vol.5, pp.291-309, 2002.

S. I. Rapoport, Hydrogen magnetic resonance spectroscopy in Alzheimer's disease, Lancet Neurol, vol.1, p.82, 2002.

R. Rathi, B. Colenbrander, M. M. Bevers, and B. M. Gadella, Evaluation of in vitro capacitation of stallion spermatozoa, Biol. Reprod, vol.65, pp.462-470, 2001.

C. Readhead, N. Takasashi, H. D. Shine, R. Saavedra, R. Sidman et al., Role of myelin basic protein in the formation of central nervous system myelin, Ann. N. Y. Acad. Sci, vol.605, pp.280-285, 1990.

J. K. Reddy and T. Hashimoto, Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system, Annu. Rev. Nutr, vol.21, pp.193-230, 2001.

P. H. Reddy and M. F. Beal, Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res, Brain Res. Rev, vol.49, pp.618-632, 2005.

T. Reed, M. Perluigi, R. Sultana, W. M. Pierce, J. B. Klein et al., Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease, Neurobiol. Dis, vol.30, pp.107-120, 2008.

H. H. Refsgaard, L. Tsai, and E. R. Stadtman, Modifications of proteins by polyunsaturated fatty acid peroxidation products, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.611-616, 2000.

E. E. Reich, W. R. Markesbery, L. J. Roberts, L. L. Swift, J. D. Morrow et al., Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease, Am. J. Pathol, vol.158, pp.293-297, 2001.

E. M. Reiman, K. Chen, X. Liu, D. Bandy, M. Yu et al., Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.6820-6825, 2009.

C. Rentero, T. Zech, C. M. Quinn, K. Engelhardt, D. Williamson et al., Functional implications of plasma membrane condensation for T cell activation, PLoS ONE, vol.3, p.2262, 2008.

J. J. Repa, G. Liang, J. Ou, Y. Bashmakov, J. M. Lobaccaro et al., Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta, Genes Dev, vol.14, pp.2819-2830, 2000.

J. Rettig, F. Wunder, M. Stocker, R. Lichtinghagen, F. Mastiaux et al., Characterization of a Shaw-related potassium channel family in rat brain, EMBO J, vol.11, pp.2473-2486, 1992.

A. Z. Reznick and L. Packer, Oxidative damage to proteins: spectrophotometric method for carbonyl assay, Meth. Enzymol, vol.233, pp.357-363, 1994.

K. J. Rhodes, K. I. Carroll, M. A. Sung, L. C. Doliveira, M. M. Monaghan et al., KChIPs and Kv4 alpha subunits as integral components of A-type potassium channels in mammalian brain, J. Neurosci, vol.24, pp.7903-7915, 2004.

C. Richter, J. W. Park, and B. N. Ames, Normal oxidative damage to mitochondrial and nuclear DNA is extensive, Proc. Natl. Acad. Sci. U.S.A, vol.85, pp.6465-6467, 1988.

P. Robert, C. U. Onyike, A. F. Leentjens, K. Dujardin, P. Aalten et al., Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders, Eur. Psychiatry, vol.24, pp.98-104, 2009.

B. R. Roberts, J. D. Doecke, A. Rembach, L. F. Yévenes, C. J. Fowler et al., Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid, Acta Neuropathol Commun, vol.4, p.119, 2016.

R. Walker, F. , Y. , and R. , Microglia, physiology and behavior: A brief commentary, Brain Behav. Immun, vol.55, pp.1-5, 2016.

M. D. Rosato-siri, E. Zambello, C. Mutinelli, N. Garbati, R. Benedetti et al., A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons, J. Pharmacol. Exp. Ther, vol.354, pp.251-260, 2015.

A. D. Roses, Apolipoprotein E and Alzheimer's disease. A rapidly expanding field with medical and epidemiological consequences, Ann. N. Y. Acad. Sci, vol.802, pp.50-57, 1996.

M. Rothe, K. Rudolf, and B. Partecke, , 2006.

, Handchir Mikrochir Plast Chir, vol.38, pp.261-266

H. Rottensteiner and F. L. Theodoulou, The ins and outs of peroxisomes: coordination of membrane transport and peroxisomal metabolism, Biochim. Biophys. Acta, vol.1763, pp.1527-1540, 2006.

A. Roumier, C. Béchade, J. Poncer, K. Smalla, E. Tomasello et al., Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse, J. Neurosci, vol.24, pp.11421-11428, 2004.

M. Rüdiger, I. Kolleck, G. Putz, R. R. Wauer, P. Stevens et al., Plasmalogens effectively reduce the surface tension of surfactant-like phospholipid mixtures, Am. J. Physiol, vol.274, pp.143-148, 1998.

M. Rüdiger, A. Tölle, W. Meier, and B. Rüstow, Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity, Am. J. Physiol. Lung Cell Mol. Physiol, vol.288, pp.379-383, 2005.

B. Rudy and C. J. Mcbain, Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing, Trends Neurosci, vol.24, pp.517-526, 2001.

B. Rudy, A. Chow, D. Lau, Y. Amarillo, A. Ozaita et al., Contributions of Kv3 channels to neuronal excitability, Ann. N. Y. Acad. Sci, vol.868, pp.304-343, 1999.

B. Rudy, C. Kentros, M. Weiser, D. Fruhling, P. Serodio et al., Region-specific expression of a K+ channel gene in brain, Proc. Natl. Acad. Sci. U.S.A, vol.89, pp.4603-4607, 1992.

D. W. Russell, Oxysterol biosynthetic enzymes, Biochim. Biophys. Acta, vol.1529, pp.126-135, 2000.

D. W. Russell, The enzymes, regulation, and genetics of bile acid synthesis, Annu. Rev. Biochem, vol.72, pp.137-174, 2003.

D. W. Russell, R. W. Halford, D. M. Ramirez, R. Shah, and T. Kotti, Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain, Annu. Rev. Biochem, vol.78, pp.1017-1040, 2009.

A. A. Saeed, G. Genové, T. Li, D. Lütjohann, M. Olin et al., Effects of a disrupted blood-brain barrier on cholesterol homeostasis in the brain, J. Biol. Chem, vol.289, pp.23712-23722, 2014.

M. J. Saganich, B. E. Schroeder, V. Galvan, D. E. Bredesen, E. H. Koo et al., Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP, J. Neurosci, vol.26, pp.13428-13436, 2006.

K. Saijo and C. K. Glass, Microglial cell origin and phenotypes in health and disease, Nat. Rev. Immunol, vol.11, pp.775-787, 2011.

M. Saito, E. P. Benson, M. Saito, and A. Rosenberg, Metabolism of cholesterol and triacylglycerol in cultured chick neuronal cells, glial cells, and fibroblasts: accumulation of esterified cholesterol in serum-free culture, J. Neurosci. Res, vol.18, pp.319-325, 1987.

A. Salmeen and D. Barford, Functions and mechanisms of redox regulation of cysteine-based phosphatases, Antioxid. Redox Signal, vol.7, pp.560-577, 2005.

H. Sampath and J. M. Ntambi, Polyunsaturated fatty acid regulation of genes of lipid metabolism, Annu. Rev. Nutr, vol.25, pp.317-340, 2005.

L. C. Sandhu, R. L. Warters, and L. A. Dethlefsen, Fluorescence studies of Hoechst 33342 with supercoiled and relaxed plasmid pBR322 DNA, Cytometry, vol.6, pp.191-194, 1985.

K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek et al., Tau suppression in a neurodegenerative mouse model improves memory function, Science, vol.309, pp.476-481, 2005.

L. E. Santos, D. Beckman, and S. T. Ferreira, Microglial dysfunction connects depression and Alzheimer's disease, Brain Behav. Immun, vol.55, pp.151-165, 2016.

M. J. Santos, M. E. Kawada, M. Espeel, C. Figueroa, A. Alvarez et al., Characterization of human peroxisomal membrane proteins, J. Biol. Chem, vol.269, pp.24890-24896, 1994.

M. J. Santos, R. A. Quintanilla, A. Toro, R. Grandy, M. C. Dinamarca et al., Peroxisomal proliferation protects from beta-amyloid neurodegeneration, J. Biol. Chem, vol.280, pp.41057-41068, 2005.

J. M. Sanz, P. Chiozzi, D. Ferrari, M. Colaianna, M. Idzko et al., Activation of microglia by amyloid {beta} requires P2X7 receptor expression, J. Immunol, vol.182, pp.4378-4385, 2009.

S. Sanz-blasco, R. A. Valero, I. Rodríguez-crespo, C. Villalobos, and L. Núñez, , 2008.

, Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs, PLoS ONE, vol.3, 2718.

M. Sastre, J. Walter, and S. M. Gentleman, Interactions between APP secretases and inflammatory mediators, J Neuroinflammation, vol.5, p.25, 2008.

S. Savary, D. Trompier, P. Andréoletti, F. Le-borgne, J. Demarquoy et al., Fatty acids -induced lipotoxicity and inflammation, Curr. Drug Metab, vol.13, pp.1358-1370, 2012.

D. P. Schafer, E. K. Lehrman, A. G. Kautzman, R. Koyama, A. R. Mardinly et al., Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner, Neuron, vol.74, pp.691-705, 2012.

J. E. Schaffer, Fatty acid transport: the roads taken, Am. J. Physiol. Endocrinol. Metab, vol.282, pp.239-246, 2002.

R. J. Schaur, W. Siems, N. Bresgen, and P. M. Eckl, 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product, Biomolecules, vol.5, pp.2247-2337, 2015.

D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron et al., Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nat. Med, vol.2, pp.864-870, 1996.

T. Schilling, F. N. Quandt, V. V. Cherny, W. Zhou, U. Heinemann et al., Upregulation of Kv1.3 K(+) channels in microglia deactivated by TGF-beta, Am. J. Physiol, vol.279, pp.1123-1134, 2000.

U. Schlattner, M. Dolder, T. Wallimann, and M. Tokarska-schlattner, , 2001.

, Mitochondrial creatine kinase and mitochondrial outer membrane porin show a direct interaction that is modulated by calcium, J. Biol. Chem, vol.276, pp.48027-48030

J. L. Schmid-burgk, D. Chauhan, T. Schmidt, T. S. Ebert, J. Reinhardt et al., A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation, J. Biol. Chem, vol.291, pp.103-109, 2016.

G. J. Schroepfer, Oxysterols: modulators of cholesterol metabolism and other processes, Physiol. Rev, vol.80, pp.361-554, 2000.

S. R. Schwid, M. D. Petrie, M. P. Mcdermott, D. S. Tierney, D. H. Mason et al., Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis, Neurology, vol.48, pp.817-821, 1997.

J. L. Segal, J. F. Thompson, and J. A. Tayek, Effects of long-term 4-aminopyridine therapy on glucose tolerance and glucokinetics in patients with spinal cord injury, Pharmacotherapy, vol.27, pp.789-792, 2007.

C. Sekirnjak, M. E. Martone, M. Weiser, T. Deerinck, E. Bueno et al., Subcellular localization of the K+ channel subunit Kv3.1b in selected rat CNS neurons, Brain Res, vol.766, pp.173-187, 1997.

D. J. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev, vol.81, pp.741-766, 2001.

N. Sergeant, A. Bretteville, M. Hamdane, M. Caillet-boudin, P. Grognet et al., Biochemistry of Tau in Alzheimer's disease and related neurological disorders, Expert Rev Proteomics, vol.5, pp.207-224, 2008.

F. Sesti, Oxidation of K(+) Channels in Aging and Neurodegeneration, Aging Dis, vol.7, pp.130-135, 2016.

F. Sesti, S. Liu, and S. Cai, Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?, Trends Cell Biol, vol.20, pp.45-51, 2010.

N. H. Shah, A. , and E. , Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration, Transl Stroke Res, vol.5, pp.38-58, 2014.

R. Shi, Y. Zhang, Y. Shi, S. Shi, and L. Jiang, Inhibition of peroxisomal ?-oxidation by thioridazine increases the amount of VLCFAs and A? generation in the rat brain, Neurosci. Lett, vol.528, pp.6-10, 2012.

M. Shichiri, Y. Adkins, N. Ishida, A. Umeno, Y. Shigeri et al., DHA concentration of red blood cells is inversely associated with markers of lipid peroxidation in men taking DHA supplement, J Clin Biochem Nutr, vol.55, pp.196-202, 2014.

R. Shin, T. P. Kruck, H. Murayama, and T. Kitamoto, A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease, Brain Res, vol.961, pp.139-146, 2003.

L. A. Shobab, G. R. Hsiung, and H. H. Feldman, Cholesterol in Alzheimer's disease, Lancet Neurol, vol.4, pp.841-852, 2005.

H. Sies, Oxidative stress: oxidants and antioxidants, Exp. Physiol, vol.82, pp.291-295, 1997.

E. Sigel, R. Baur, G. Trube, H. Möhler, and P. Malherbe, The effect of subunit composition of rat brain GABAA receptors on channel function, Neuron, vol.5, pp.703-711, 1990.

A. R. Simard and S. Rivest, Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease, Mol. Psychiatry, vol.11, pp.327-335, 2006.

M. Simard and M. Nedergaard, The neurobiology of glia in the context of water and ion homeostasis, Neuroscience, vol.129, pp.877-896, 2004.

N. A. Simonian and J. T. Coyle, Oxidative stress in neurodegenerative diseases, Annu. Rev. Pharmacol. Toxicol, vol.36, pp.83-106, 1996.

K. Simons and E. Ikonen, Functional rafts in cell membranes, Nature, vol.387, pp.569-572, 1997.

M. Simons, P. Keller, B. De-strooper, K. Beyreuther, C. G. Dotti et al., Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons, Proc. Natl. Acad. Sci. U.S.A, vol.95, pp.6460-6464, 1998.

J. E. Simpson, P. G. Ince, G. Lace, G. Forster, P. J. Shaw et al., Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain, and MRC Cognitive Function and Ageing Neuropathology Study Group, vol.31, pp.578-590, 2010.

H. Singh, K. Beckman, and A. Poulos, Exclusive localization in peroxisomes of dihydroxyacetone phosphate acyltransferase and alkyl-dihydroxyacetone phosphate synthase in rat liver, J. Lipid Res, vol.34, pp.467-477, 1993.

S. K. Singhrao, J. W. Neal, S. J. Piddlesden, and G. R. Newman, New immunocytochemical evidence for a neuronal/oligodendroglial origin for corpora amylacea, Neuropathol. Appl. Neurobiol, vol.20, pp.66-73, 1994.

L. J. Siskind, Mitochondrial ceramide and the induction of apoptosis, J. Bioenerg. Biomembr, vol.37, pp.143-153, 2005.

V. P. Skulachev, Possible role of reactive oxygen species in antiviral defense, Biochemistry Mosc, vol.63, pp.1438-1440, 1998.

L. L. Smith, J. , and B. H. , Biological activities of oxysterols. Free Radic, Biol. Med, vol.7, pp.285-332, 1989.

M. Söderberg, C. Edlund, I. Alafuzoff, K. Kristensson, and G. Dallner, Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type, J. Neurochem, vol.59, pp.1646-1653, 1992.

R. K. Sodhi and N. Singh, Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia, Eur. J. Pharmacol, vol.732, pp.50-59, 2014.

M. V. Sofroniew and H. V. Vinters, Astrocytes: biology and pathology, Acta Neuropathol, vol.119, pp.7-35, 2010.

A. Soldano and B. A. Hassan, Beyond pathology: APP, brain development and Alzheimer's disease, Curr. Opin. Neurobiol, vol.27, pp.61-67, 2014.

B. Soliven, S. Szuchet, B. G. Arnason, and D. J. Nelson, Expression and modulation of K+ currents in oligodendrocytes: possible role in myelinogenesis, Dev. Neurosci, vol.11, pp.118-131, 1989.

A. Solomon, V. Leoni, M. Kivipelto, A. Besga, A. R. Oksengård et al., Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease, Neurosci. Lett, vol.462, pp.89-93, 2009.

I. Sommer and M. Schachner, Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system, Dev. Biol, vol.83, pp.311-327, 1981.

Y. Son, W. Chun, Y. Ahn, K. Kim, C. Lee et al., 7-Ketocholesterol induces the reduction of KCNMB1 in atherosclerotic blood vessels, Biochem. Biophys. Res. Commun, vol.457, pp.324-327, 2015.

L. Spinney, Alzheimer's disease: The forgetting gene, Nature, vol.510, pp.26-28, 2014.

B. Stansley, J. Post, and K. Hensley, A comparative review of cell culture systems for the study of microglial biology in Alzheimer's disease, J Neuroinflammation, vol.9, p.115, 2012.

B. Stecca, C. M. Southwood, A. Gragerov, K. A. Kelley, V. L. Friedrich et al., The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin, J. Neurosci, vol.20, pp.4002-4010, 2000.

N. Stence, M. Waite, and M. E. Dailey, Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices, Glia, vol.33, pp.256-266, 2001.

C. J. Steves, T. D. Spector, J. , and S. H. , Ageing, genes, environment and epigenetics: what twin studies tell us now, and in the future, Age Ageing, vol.41, pp.581-586, 2012.

K. M. Stiefel, B. Torben-nielsen, and J. S. Coggan, Proposed evolutionary changes in the role of myelin, Front Neurosci, vol.7, p.202, 2013.

G. B. Stokin, C. Lillo, T. L. Falzone, R. G. Brusch, E. Rockenstein et al., Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease, Science, vol.307, pp.1282-1288, 2005.

N. Strazielle and J. F. Ghersi-egea, Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules, Mol. Pharm, vol.10, pp.1473-1491, 2013.

W. J. Streit, S. A. Walter, and N. A. Pennell, Reactive microgliosis, Prog. Neurobiol, vol.57, pp.563-581, 1999.

M. Strupp, R. Kalla, S. Glasauer, J. Wagner, K. Hüfner et al., Aminopyridines for the treatment of cerebellar and ocular motor disorders, Prog. Brain Res, vol.171, pp.535-541, 2008.

L. A. Sturtz, K. Diekert, L. T. Jensen, R. Lill, and V. C. Culotta, A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage, J. Biol. Chem, vol.276, pp.38084-38089, 2001.

, Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate, J. Biol. Chem, vol.272, pp.22364-22372

W. Walz, Role of astrocytes in the clearance of excess extracellular potassium, Neurochem. Int, vol.36, pp.291-300, 2000.

W. Walz and L. K. Bekar, Ion channels in cultured microglia, Microsc. Res. Tech, vol.54, pp.26-33, 2001.

J. Wang, S. Xiong, C. Xie, W. R. Markesbery, and M. A. Lovell, Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease, J. Neurochem, vol.93, pp.953-962, 2005.

X. Wang, B. Su, H. Lee, X. Li, G. Perry et al., Impaired balance of mitochondrial fission and fusion in Alzheimer's disease, J. Neurosci, vol.29, pp.9090-9103, 2009.

X. Wang, W. Wang, L. Li, G. Perry, H. Lee et al., Oxidative stress and mitochondrial dysfunction in Alzheimer's disease, Biochim. Biophys. Acta, vol.1842, pp.1240-1247, 2014.

Y. Wang, P. M. Rogers, C. Su, G. Varga, K. R. Stayrook et al., Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J. Biol. Chem, vol.283, pp.26332-26339, 2008.

Y. Wang, P. M. Rogers, C. Su, G. Varga, K. R. Stayrook et al., Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J. Biol. Chem, vol.283, pp.26332-26339, 2008.

A. E. Warrington, E. Barbarese, and S. E. Pfeiffer, Stage specific, (O4+GalC-) isolated oligodendrocyte progenitors produce MBP+ myelin in vivo, Dev. Neurosci, vol.14, pp.93-97, 1992.

A. M. Waszkielewicz, A. Gunia, N. Szkaradek, K. S?oczy?ska, S. Krupi?ska et al., Ion channels as drug targets in central nervous system disorders, Curr. Med. Chem, vol.20, pp.1241-1285, 2013.

L. Wei, A. Y. Xiao, C. Jin, A. Yang, Z. Y. Lu et al., Effects of chloride and potassium channel blockers on apoptotic cell shrinkage and apoptosis in cortical neurons, Pflugers Arch, vol.448, pp.325-334, 2004.

M. D. Weingarten, A. H. Lockwood, S. Y. Hwo, and M. W. Kirschner, A protein factor essential for microtubule assembly, Proc. Natl. Acad. Sci. U.S.A, vol.72, pp.1858-1862, 1975.

M. Weiser, E. Bueno, C. Sekirnjak, M. E. Martone, H. Baker et al., The potassium channel subunit KV3.1b is localized to somatic and axonal membranes of specific populations of CNS neurons, J. Neurosci, vol.15, pp.4298-4314, 1995.

M. Weiser, E. Vega-saenz-de-miera, C. Kentros, H. Moreno, L. Franzen et al., Differential expression of Shaw-related K+ channels, 1994.

P. Wostyn, D. Van-dam, K. Audenaert, and P. P. De-deyn, Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease, Int J Alzheimers Dis, p.617420, 2011.

A. L. Wright, R. Zinn, B. Hohensinn, L. M. Konen, S. B. Beynon et al., Neuroinflammation and neuronal loss precede A? plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease, PLoS ONE, vol.8, p.59586, 2013.

C. Wu, C. Kaur, V. Sivakumar, J. Lu, and E. Ling, Kv1.1 expression in microglia regulates production and release of proinflammatory cytokines, endothelins and nitric oxide, Neuroscience, vol.158, pp.1500-1508, 2009.

K. W. Wu, P. Yang, S. S. Li, C. W. Liu, and F. Y. Sun, VEGF attenuated increase of outward delayed-rectifier potassium currents in hippocampal neurons induced by focal ischemia via PI3-K pathway, Neuroscience, vol.298, pp.94-101, 2015.

H. Wulff, N. A. Castle, and L. A. Pardo, Voltage-gated potassium channels as therapeutic targets, Nat Rev Drug Discov, vol.8, pp.982-1001, 2009.

T. Wyss-coray, R. , and J. , Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med 2, p.6346, 2012.

T. Wyss-coray, J. D. Loike, T. C. Brionne, E. Lu, R. Anankov et al., Adult mouse astrocytes degrade amyloid-beta in vitro and in situ, Nat. Med, vol.9, pp.453-457, 2003.

Q. Xiao, P. Yan, X. Ma, H. Liu, R. Perez et al., Enhancing astrocytic lysosome biogenesis facilitates A? clearance and attenuates amyloid plaque pathogenesis, J. Neurosci, vol.34, pp.9607-9620, 2014.

J. Xu, S. Chen, G. Ku, S. H. Ahmed, J. Xu et al., Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation, J. Cereb. Blood Flow Metab, vol.21, pp.702-710, 2001.

M. Yamada, Cerebral amyloid angiopathy and gene polymorphisms, J. Neurol. Sci, vol.226, pp.41-44, 2004.

H. Yamamoto, Y. Saitoh, K. Fukunaga, H. Nishimura, and E. Miyamoto, Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly, J. Neurochem, vol.50, pp.1614-1623, 1988.

D. Yan and V. M. Olkkonen, Characteristics of oxysterol binding proteins, Int. Rev. Cytol, vol.265, pp.253-285, 2008.

M. Yanagi, R. H. Joho, S. A. Southcott, A. A. Shukla, S. Ghose et al., Kv3.1-containing K(+) channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs, Mol. Psychiatry, vol.19, pp.573-579, 2014.

L. Yang, N. D. Thomas, and C. J. Helke, Characterization of substance P release from the intermediate area of rat thoracic spinal cord, Synapse, vol.23, pp.265-273, 1996.

C. M. Yates, J. Butterworth, M. C. Tennant, G. , and A. , Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias, J. Neurochem, vol.55, pp.1624-1630, 1990.

H. Ye, S. Jalini, S. Mylvaganam, C. , and P. , Activation of large-conductance Ca(2+)-activated K(+) channels depresses basal synaptic transmission in the hippocampal CA1 area in APP (swe/ind) TgCRND8 mice, Neurobiol. Aging, vol.31, pp.591-604, 2010.

P. L. Yeagle, Cholesterol and the cell membrane, Biochim. Biophys. Acta, vol.822, pp.267-287, 1985.

S. Yehuda, S. Rabinovitz, R. L. Carasso, and D. I. Mostofsky, The role of polyunsaturated fatty acids in restoring the aging neuronal membrane, Neurobiol. Aging, vol.23, pp.843-853, 2002.

S. H. Yen, F. Gaskin, and S. M. Fu, Neurofibrillary tangles in senile dementia of the Alzheimer type share an antigenic determinant with intermediate filaments of the vimentin class, Am. J. Pathol, vol.113, pp.373-381, 1983.

H. Yin, H. Wang, H. Zhang, N. Gao, T. Zhang et al., Resveratrol Attenuates A?-Induced Early Hippocampal Neuron Excitability Impairment via Recovery of Function of Potassium Channels, Neurotox Res, 2017.

R. Yirmiya, N. Rimmerman, and R. Reshef, Depression as a microglial disease, Trends Neurosci, vol.38, pp.637-658, 2015.

S. Yokoyama, K. Imoto, T. Kawamura, H. Higashida, N. Iwabe et al., Potassium channels from NG108-15 neuroblastoma-glioma hybrid cells. Primary structure and functional expression from cDNAs, FEBS Lett, vol.259, pp.37-42, 1989.

T. Yoshikawa, H. Shimano, N. Yahagi, T. Ide, M. Amemiya-kudo et al., Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements, J. Biol. Chem, vol.277, pp.1705-1711, 2002.

S. P. Yu, C. H. Yeh, S. L. Sensi, B. J. Gwag, L. M. Canzoniero et al., Mediation of neuronal apoptosis by enhancement of outward potassium current, Science, vol.278, pp.114-117, 1997.

M. Zacchia, M. L. Abategiovanni, S. Stratigis, and G. Capasso, Potassium: From Physiology to Clinical Implications, Kidney Dis (Basel), vol.2, pp.72-79, 2016.

A. Zarrouk, T. Nury, A. Dauphin, P. Frère, J. Riedinger et al., Impact of C24:0 on actinmicrotubule interaction in human neuronal SK-N-BE cells: evaluation by FRET confocal spectral imaging microscopy after dual staining with rhodamine-phalloidin and tubulin tracker green, Funct. Neurol, vol.30, pp.33-46, 2015.

A. Zarrouk, J. Riedinger, S. H. Ahmed, S. Hammami, W. Chaabane et al., Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia, J. Alzheimers Dis, vol.44, pp.1349-1359, 2015.

A. Zarrouk, A. Vejux, T. Nury, H. I. El-hajj, M. Haddad et al., Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E), Oxid Med Cell Longev, p.623257, 2012.

G. Zeidner, R. Sadja, and E. Reuveny, Redox-dependent gating of G protein-coupled inwardly rectifying K+ channels, J. Biol. Chem, vol.276, pp.35564-35570, 2001.

Z. Berry, K. A. Murphy, and R. C. , Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids, J. Am. Soc. Mass Spectrom, vol.15, pp.1499-1508, 2004.

Y. Zhan, R. C. Paolicelli, F. Sforazzini, L. Weinhard, G. Bolasco et al., Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior, Nat. Neurosci, vol.17, pp.400-406, 2014.

Z. Zhang, D. Li, D. E. Blanchard, S. R. Lear, S. K. Erickson et al., Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations, J. Lipid Res, vol.42, pp.649-658, 2001.

C. Zhao and K. Dahlman-wright, Liver X receptor in cholesterol metabolism, J. Endocrinol, vol.204, pp.233-240, 2010.

F. Zhou, H. Yao, J. Wu, J. Ding, T. Sun et al., Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation, J. Cell. Mol. Med, vol.12, pp.1559-1570, 2008.

J. Zhou, C. Yang, J. Zhong, and H. Wang, Intrathecal TRESK gene recombinant adenovirus attenuates spared nerve injury-induced neuropathic pain in rats, Neuroreport, vol.24, pp.131-136, 2013.

F. Zhu, J. Qian, and G. Pan, Application of IL-1 beta and 8 mRNA and some other indices in monitoring the activity of ulcerative colitis, 1999.

, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol.21, pp.384-389

R. A. Zoeller, A. C. Lake, N. Nagan, D. P. Gaposchkin, M. A. Legner et al., Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether, Biochem. J, vol.338, pp.769-776, 1999.

R. A. Zoeller, O. H. Morand, and C. R. Raetz, A possible role for plasmalogens in protecting animal cells against photosensitized killing, J. Biol. Chem, vol.263, pp.11590-11596, 1988.

M. Zonta, M. C. Angulo, S. Gobbo, B. Rosengarten, K. Hossmann et al., Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation, Nat. Neurosci, vol.6, pp.43-50, 2003.

. Wood, Introduction Sterols and fatty acids are thought to participate in ageing processes, 2014.

. Giudetti, Cholesterol oxide derivatives, also named oxysterols, which are formed by cholesterol autooxidation or enzymatically or by both mechanisms, 2004.

. Mutemberezi, have been identified at increased levels in the body fluids (plasma, cerebrospinal fluid (CSF)) and in the brain of patients with Alzheimer's disease (AD) (Björkhem, 2006.

. Hascalovici, Induction of apoptosis by intracellular potassium ion depletion: using the fluorescent dye PBFI in a 96-well plate method in cultured lung cancer cells, multiple sclerosis (MS), vol.20, pp.986-994, 2002.

M. P. Ares, M. I. Pörn-ares, S. Moses, J. Thyberg, L. Juntti-berggren et al., , p.7, 2000.

M. Bezine, Evidence of K + homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes, Chem. Phys. Lipids, 2017.
URL : https://hal.archives-ouvertes.fr/pasteur-01964971

C. Induces, 2+) oscillations: MAP kinase activation and apoptosis in human aortic smooth muscle cells, Atherosclerosis, vol.153, pp.23-35

S. Arnauld, M. Fidaleo, M. C. Clémencet, G. Chevillard, A. Athias et al., Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14, Biochimie, vol.643, pp.1376-1386, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00495612

M. Baarine, K. Ragot, E. C. Genin, H. El-hajj, D. Trompier et al., Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N: 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes, J. Neurochem, vol.111, pp.119-131, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00514890

M. Baarine, P. Andréoletti, A. Athias, T. Nury, A. Zarrouk et al., Evidence of oxidative stress in very long chain fatty acidtreated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins, Neuroscience, vol.213, pp.1-18, 2012.

M. Baarine, K. Ragot, A. Athias, T. Nury, Z. Kattan et al., Incidence of Abcd1 level on the induction of cell death and organelle dysfunctions triggered by very long chain fatty acids and TNF-a on oligodendrocytes and astrocytes, Neurotoxicology, vol.33, pp.212-228, 2012.

A. Barateiro, D. Brites, and A. Fernandes, Oligodendrocyte development and myelination in neurodevelopment: molecular mechanisms in health and disease, Curr. Pharm. Des, vol.22, pp.656-679, 2016.

B. Barriuso, D. Ansorena, and I. Astiasarán, Oxysterols formation: a review of a multifactorial process, J. Steroid Biochem. Mol. Biol, vol.16, pp.960-0760, 2016.

N. Baumann and D. Pham-dinh, Biology of oligodendrocyte and myelin in the mammalian central nervous system, Physiol. Rev, vol.81, pp.871-927, 2001.

M. E. Beattie, S. L. Veatch, B. L. Stottrup, and S. L. Keller, Sterol structure determines miscibility versus melting transitions in lipid vesicles, Biophys. J, vol.89, pp.1760-1768, 2005.

A. Berthier, S. Lemaire-ewing, C. Prunet, T. Montange, A. Vejux et al., 7-ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways, FEBS J, vol.272, pp.3093-3104, 2005.

L. Bezman and H. W. Moser, Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes, Am. J. Med. Genet, vol.76, pp.415-419, 1998.

I. Björkhem, Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain, Intern. Med, vol.260, pp.493-508, 2006.

S. Boenzi, F. Deodato, R. Taurisano, B. M. Goffredo, C. Rizzo et al., Evaluation of plasma cholestane-3b, 5a, 6b-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism, Lipid Res, vol.57, pp.361-367, 2016.

M. D. Bootman, T. J. Collins, C. M. Peppiatt, L. S. Prothero, L. Mackenzie et al., Calcium signalling-an overview, Semin. Cell Dev. Biol, vol.12, pp.3-10, 2001.

D. C. Broom, D. J. Matson, E. Bradshaw, M. E. Buck, R. Meade et al., Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation, Pharmacol. Exp. Ther, vol.327, pp.620-633, 2008.

C. Chen, L. Wang, X. Rong, W. Wang, and X. Wang, Effects of fluoxetine on protein expression of potassium ion channels in the brain of chronic mild stress rats, Acta Pharm. Sin. B, vol.5, pp.55-61, 2015.

B. H. Choi, J. S. Choi, S. H. Yoon, D. J. Rhie, D. S. Min et al., Effects of norfluoxetine, the major metabolite of fluoxetine, on the cloned neuronal potassium channel Kv3, Neuropharmacology, vol.1, pp.443-453, 2001.

M. L. Cotrina and M. Nedergaard, Physiological and pathological functions of P2 X7 receptor in the spinal cord, Purinergic Signal, vol.5, pp.223-232, 2009.

P. J. Crick, W. J. Griffiths, J. Zhang, M. Beibel, J. Abdel-khalik et al., Reduced plasma levels of 25-hydroxycholesterol and increased cerebrospinal fluid levels of bile acid precursors in multiple sclerosis patients, Mol. Neurobiol. PubMed PMID, p.27878760, 2016.

M. Díaz-hernández, M. Díez-zaera, J. Sánchez-nogueiro, R. Gómez-villafuertes, J. M. Canals et al., Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration, FASEB J, vol.23, pp.1893-1906, 2009.

S. R. Datta, A. Brunet, and M. E. Greenberg, Cellular survival: a play in three Akts, Genes Dev, vol.13, pp.2905-2927, 1999.

M. Debbabi, T. Nury, A. Zarrouk, N. Mekahli, M. Bezine et al., Protective effects of a-tocopherol, g-tocopherol and oleic acid, three compounds of olive oils, and no effect of trolox, on 7-ketocholesterol-induced mitochondrial and peroxisomal dysfunction in microglial BV-2 cells, Int. J. Mol. Sci, vol.17, issue.12, 2016.

M. Doria, L. Maugest, T. Moreau, G. Lizard, and A. Vejux, Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease. Free Radic, Biol. Med, vol.101, pp.393-400, 2016.

M. J. Duran, S. V. Pierre, P. Lesnik, G. Pieroni, M. Bourdeaux et al., 7-ketocholesterol inhibits Na, K-ATPase activity by decreasing expression of its a1-subunit and membrane fluidity in human endothelial cells, Cell Mol. Biol, vol.56, pp.1434-1441, 2010.

H. I. El-sayyad, Cholesterol overload impairing cerebellar function: the promise of natural products, Nutrition, vol.31, pp.621-630, 2015.

M. Engelen, S. Kemp, M. De-visser, B. M. Van-geel, R. J. Wanders et al., X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management, Curr. Neurol. Neurosci. Rep, vol.14, p.486, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00755770

A. C. Feutz, D. Pham-dinh, B. Allinquant, M. Miehe, and M. S. Ghandour, An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway, Glia, vol.34, pp.241-252, 2001.

A. M. Giudetti, A. Romano, A. M. Lavecchia, and S. Gaetani, The role of brain cholesterol and its oxidized products in Alzheimer's disease, Curr. Alzheimer Res, vol.13, pp.198-205, 2016.

S. F. Graham, M. B. Nasarauddin, M. Carey, B. Mcguinness, C. Holscher et al., Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies, Alzheimers Dis, vol.44, pp.851-857, 2015.

S. Grissmer, A. N. Nguyen, J. Aiyar, D. C. Hanson, R. J. Mather et al., Pharmacological characterization of five cloned voltage-gated K + channels, types Kv1. 1, 1. 2, 1. 3, 1. 5, and 3. 1, stably expressed in mammalian cell lines, Mol. Pharmacol, vol.45, pp.1227-1234, 1994.

S. Hadavi, M. D. Baker, and R. Dobson, Sustained-release fampridine in multiple sclerosis, Mult. Scler. Relat. Disord, vol.3, pp.17-21, 2017.

Y. Hammoud, T. Rice, and J. J. Mackrill, Oxysterols modulate calcium signalling in the A7r5 aortic smooth muscle cell-line, Biochimie, vol.95, pp.568-577, 2013.

J. R. Hascalovici, J. Vaya, S. Khatib, C. A. Holcroft, H. Zukor et al., Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1, J. Neurochem, vol.110, pp.1241-1253, 2009.

S. Hein, P. Schönfeld, S. Kahlert, and G. Reiser, Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture, Hum. Mol. Genet, vol.17, pp.1750-1761, 2008.

M. Heverin, N. Bogdanovic, D. Lütjohann, T. Bayer, I. Pikuleva et al., Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease, J. Lipid Res, vol.45, pp.186-193, 2004.

H. Hu, Y. Zhou, T. Leng, A. Liu, Y. Wang et al., The major cholesterol metabolite cholestane-3b, 5a, 6b-triol functions as an endogenous neuroprotectant, J. Neurosci, vol.34, pp.11426-11438, 2014.

J. D. Huang, J. Amaral, J. W. Lee, and I. R. Rodriguez, 7-Ketocholesterol-induced inflammation signals mostly through the TLR4 receptor both in vitro and in vivo, PLoS One, vol.9, issue.7, p.100985, 2014.

J. Jang, S. Park, H. Hur, . Jin, H. J. Cho et al., 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome, Nat. Commun, vol.7, p.13129, 2016.

S. E. Jarvis and G. W. Zamponi, Trafficking and regulation of neuronal voltagegated calcium channels, Curr. Opin. Cell Biol, vol.19, pp.474-482, 2007.

E. Kahn, M. Baarine, A. Dauphin, K. Ragot, N. Tissot et al., Impact of 7-ketocholesterol and very long chain fatty acids on oligodendrocyte lipid membrane organization: evaluation via LAURDAN and FAMIS spectral image analysis, Cytom. A, vol.79, pp.293-305, 2011.

F. Kannenberg, J. R. Nofer, E. Schulte, J. Reunert, T. Marquardt et al., Determination of serum cholestane-3b, 5a, 6b-triol by gas chromatographymass spectrometry for identification of Niemann, 2016.

, Steroid Biochem. Mol. Biol, issue.16, pp.30044-30053, 2016.

S. E. Kasner and M. B. Ganz, Regulation of intracellular potassium in mesangial cells: a fluorescence analysis using the dye, PBFI, Am. J. Physiol, vol.262, pp.462-467, 1992.

J. Kim, Y. Sasaki, W. Yoshida, N. Kobayashi, A. J. Veloso et al., Rapid cytotoxicity screening platform for amyloid inhibitors using a membrane-potential sensitive fluorescent probe, Anal. Chem, vol.85, pp.185-192, 2013.

H. K. Kim, P. V. Nunes, K. C. Oliveira, L. T. Young, and B. Lafer, Neuropathological relationship between major depression and dementia: a hypothetical model and review, Prog. Neuropsychopharmacol. Biol. Psychiatry, vol.67, pp.51-57, 2016.
DOI : 10.1016/j.pnpbp.2016.01.008

S. M. Kim, M. Y. Noh, H. Kim, S. Y. Cheon, K. M. Lee et al., 25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis, Oncotarget doi, 2017.

K. Kiselyov and S. Muallem, ROS and intracellular ion channels, Cell Calcium, vol.60, pp.108-114, 2016.
DOI : 10.1016/j.ceca.2016.03.004

URL : http://europepmc.org/articles/pmc4996699?pdf=render

S. Kitayama, H. Ohtsuki, K. Morita, T. Dohi, and A. Tsujimoto, Bis-oxonol experiment on plasma membrane potentials of bovine adrenal chromaffin cells: depolarizing stimuli and their possible interaction, Neurosci. Lett, vol.116, pp.275-279, 1990.

G. Klinke, M. Rohrbach, R. Giugliani, P. Burda, M. R. Baumgartner et al., LC-MS/MS based assay and reference intervals in children and adolescents for oxysterols elevated in Niemann-Pick diseases, Clin. Biochem, vol.48, pp.596-602, 2015.

D. J. Klionsky, K. Abdelmohsen, A. Abe, M. J. Abedin, H. Abeliovich et al., Guidelines for the use and interpretation of assays for monitoring autophagy, Autophagy, vol.12, pp.1-222, 2017.
URL : https://hal.archives-ouvertes.fr/hal-00735751

A. Kondratskyi, K. Kondratska, R. Skryma, and N. Prevarskaya, Ion channels in the regulation of apoptosis, Biochim. Biophys. Acta, vol.1848, issue.10, pp.2532-2546, 2015.

J. Kou, G. G. Kovacs, R. Höftberger, W. Kulik, A. Brodde et al., Peroxisomal alterations in Alzheimer's disease, Acta Neuropathol, vol.122, pp.271-283, 2011.

F. Kreilaus, A. S. Spiro, C. A. Mclean, B. Garner, and A. M. Jenner, Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue, Neuropathol. Appl. Neurobiol, vol.42, pp.535-546, 2016.
DOI : 10.1111/nan.12286

URL : http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1629&context=ihmri

N. Kruska, P. Schönfeld, A. Pujol, and G. Reiser, Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophy-associated very long-chain fatty acids target several cellular energy-dependent functions, Biochim. Biophys. Acta, vol.1852, pp.925-936, 2015.
DOI : 10.1016/j.bbadis.2015.01.005

URL : https://doi.org/10.1016/j.bbadis.2015.01.005

A. Kumar, S. Kumari, R. K. Majhi, N. Swain, M. Yadav et al., Regulation of TRP channels by steroids: implications in physiology and diseases, Gen. Comp. Endocrinol, vol.220, pp.23-32, 2015.

P. Kumar, D. Kumar, S. K. Jha, N. K. Jha, and R. K. Ambasta, Ion channels in neurological disorders, Adv. Protein Chem. Struct. Biol, vol.103, pp.97-136, 2016.
DOI : 10.1016/bs.apcsb.2015.10.006

K. Kunzelmann, Ion channels in regulated cell death, Cell. Mol. Life Sci, vol.73, pp.2387-2403, 2016.
DOI : 10.1007/s00018-016-2208-z

T. Laakko, L. King, and P. Fraker, Versatility of merocyanine 540 for the flow cytometric detection of apoptosis in human and murine cells, J. Immunol. Methods, vol.261, pp.129-139, 2002.

J. J. Lahet, F. Lenfant, C. Courderot-masuyer, F. Bouyer, J. Lecordier et al., Comparison of three methods for oxidative stressinduced potassium efflux measurement, Biomed. Pharmacother, vol.61, pp.423-426, 2007.

M. Langner and S. W. Hui, Merocyanine interaction with phosphatidylcholine bilayers, Biochim. Biophys. Acta, vol.1149, pp.175-179, 1993.
DOI : 10.1016/0005-2736(93)90038-2

C. S. Lee, W. J. Park, E. S. Han, and H. Bang, Differential modulation of 7-ketocholesterol toxicity against PC12 cells by calmodulin antagonists and Ca2+ channel blockers, Neurochem. Res, vol.32, pp.87-98, 2007.

S. Lemaire-ewing, A. Berthier, M. C. Royer, E. Logette, L. Corcos et al., 2009. 7beta-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent, Cell Biol. Toxicol, vol.25, pp.127-139

V. Leoni, T. Masterman, U. Diczfalusy, G. De-luca, J. Hillert et al., Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis, Neurosci. Lett, vol.331, pp.163-166, 2002.

V. Leoni, T. Nury, A. Vejux, A. Zarrouk, C. Caccia et al., Mitochondrial dysfunctions in 7-ketocholesteroltreated 158N oligodendrocytes without or with a-tocopherol: impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors, Steroid Biochem. Mol. Biol. doi, 2016.

F. Li and J. Z. Tsien, Memory and the NMDA receptors, N. Engl. J. Med, vol.361, pp.302-303, 2009.

D. Liu, M. Pitta, J. H. Lee, B. Ray, D. K. Lahiri et al., The KATP channel activator diazoxide ameliorates amyloid-b and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease, Alzheimers Dis, vol.22, pp.443-457, 2010.

G. Lizard, S. Fournel, L. Genestier, N. Dhedin, C. Chaput et al., Kinetics of plasma membrane and mitochondrial alterations in cells undergoing apoptosis, Cytometry, vol.21, pp.275-283, 1995.

G. Lizard, Generation of oxysterols formed by free radical and enzymes by electrochemical oxidation, Eur. J. Lipid Sci. Technol, vol.118, pp.135-136, 2016.

S. Lordan, N. M. O'brien, and J. J. Mackrill, The role of calcium in apoptosis induced by 7beta-hydroxycholesterol and cholesterol-5beta, 6beta-epoxide, Biochem. Mol. Toxicol, vol.23, pp.324-332, 2009.

J. J. Mackrill, Oxysterols and calcium signal transduction, Chem. Phys. Lipids, vol.164, pp.488-495, 2011.
DOI : 10.1016/j.chemphyslip.2011.04.001

E. Millanvoye-van-brussel, G. Topal, A. Brunet, T. Do-pham, V. Deckert et al., Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2, Biochem. J, vol.380, pp.533-539, 2004.

S. Monier, M. Samadi, C. Prunet, M. Denance, A. Laubriet et al., Impairment of the cytotoxic and oxidative activities of 7beta hydroxycholesterol and 7-ketocholesterol by esterification with oleate, Biochem. Biophys. Res. Commun, vol.303, pp.814-824, 2003.

J. E. Morley and W. A. Banks, Lipids and cognition, Alzheimers Dis, vol.20, pp.737-747, 2010.
DOI : 10.3233/jad-2010-091576

A. L. Moyano, K. Pituch, G. Li, R. Van-breemen, J. E. Mansson et al., Levels of plasma sulfatides C18:0 and C24:1 correlate with disease status in relapsing-remitting multiple sclerosis, J. Neurochem, vol.127, pp.600-604, 2013.

S. Mukhopadhyay, K. Fellows, R. W. Browne, P. Khare, S. Krishnan-radhakrishnan et al., , 2016.

. Mult, . Scler, and . Doi,

V. Mutemberezi, O. Guillemot-legris, and G. G. Muccioli, Oxysterols: from cholesterol metabolites to key mediators, Prog. Lipid Res, vol.64, pp.152-169, 2016.
DOI : 10.1016/j.plipres.2016.09.002

L. Novakova, M. Axelsson, C. Malmeström, H. Zetterberg, I. Björkhem et al., Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis, Neurol. Sci, vol.358, pp.201-206, 2015.

T. Nury, A. Zarrouk, J. J. Mackrill, M. Samadi, P. Durand et al., Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7b-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of a-tocopherol and docosahexaenoic acid, Steroids, vol.99, pp.194-203, 2015.

T. Nury, A. Zarrouk, K. Ragot, M. Debbabi, J. Riedinger et al., 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: potential roles of 7-ketocholesterol in the pathophysiology of X-ALD, Steroid Biochem. Mol. Biol. doi, 2016.

E. Olivier, M. Dutot, A. Regazzetti, D. Dargère, N. Auzeil et al., Lipid deregulation in UV irradiated skin cells: role of 25-hydroxycholesterol in keratinocyte differentiation during photoaging, J. Steroid Biochem. Mol. Biol. doi, 2016.

E. Olivier, M. Dutot, A. Regazzetti, T. Leguillier, D. Dargère et al., P2X7-pannexin-1 and amyloid (-induced oxysterol input in human retinal cell: role in age-related macular degeneration?, Biochimie, vol.127, pp.70-78, 2016.

V. M. Olkkonen and R. Hynynen, Interactions of oxysterols with membranes and proteins, Mol. Asp. Med, vol.30, pp.123-133, 2009.

S. R. Panini and M. S. Sinensky, Mechanisms of oxysterol-induced apoptosis, Curr. Opin. Lipidol, vol.12, pp.529-533, 2001.

S. M. Paul, J. J. Doherty, A. J. Robichaud, G. M. Belfort, B. Y. Chow et al., The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors, J. Neurosci, vol.33, pp.17290-17300, 2013.

A. M. Petrov, M. R. Kasimov, and A. L. Zefirov, Brain cholesterol metabolism and its defects: linkage to neurodegenerative diseases and synaptic dysfunction, Acta Nat, vol.8, pp.58-73, 2016.

J. S. Poling, J. W. Karanian, N. Salem, and S. Vicini, Time-and voltage-dependent block of delayed rectifier potassium channels by docosahexaenoic acid, Mol. Pharmacol, vol.47, pp.381-390, 1995.

J. S. Poling, S. Vicini, M. A. Rogawski, and N. Salem, Docosahexaenoic acid block of neuronal voltage-gated K+ channels: subunit selective antagonism by zinc, Neuropharmacology, vol.35, pp.969-982, 1996.

F. D. Porter, D. E. Scherrer, M. H. Lanier, S. J. Langmade, V. Molugu et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease, Sci. Transl. Med, vol.2, issue.56, pp.56-81, 2010.

K. Ragot, J. J. Mackrill, A. Zarrouk, T. Nury, V. Aires et al., Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes, Biochem. Pharmacol, vol.86, pp.67-79, 2013.

S. Ramasamy, G. A. Boissonneault, and B. Hennig, Oxysterol-induced endothelial cell dysfunction in culture, J. Am. Coll. Nutr, vol.11, pp.532-538, 1992.

B. R. Roberts, J. D. Doecke, A. Rembach, L. F. Yévenes, C. J. Fowler et al., Rubidium and potassium levels are altered in Alzheimer's disease brain and blood but not in cerebrospinal fluid, Acta Neuropathol. Commun, vol.4, p.119, 2016.

S. Roger, P. Pelegrin, and A. Surprenant, Facilitation of P2X7 receptor currents and membrane blebbing via constitutive and dynamic calmodulin binding, J. Neurosci, vol.28, pp.6393-6401, 2008.

M. Romanello, S. Zampieri, N. Bortolotti, L. Deroma, A. Sechi et al., Comprehensive evaluation of plasma 7-ketocholesterol and cholestan3b, 5a, 6b-Triol in an Italian cohort of patients affected by niemann-pick disease due to NPC1 and SMPD1 mutations, Clin. Chim. Acta, vol.455, pp.39-45, 2016.

L. Ryan, Y. C. O'callaghan, and N. M. O'brien, Involvement of calcium in 7beta -hydroxycholesterol and cholesterol-5beta, 6beta -epoxide-induced apoptosis, Int. J. Toxicol, vol.25, pp.35-39, 2006.

J. M. Sanz, P. Chiozzi, D. Ferrari, M. Colaianna, M. Idzko et al., Activation of microglia by amyloid {beta} requires P2X7 receptor expression, J. Immunol, vol.182, pp.4378-4385, 2009.

S. Savary, D. Trompier, P. Andréoletti, F. Le-borgne, J. Demarquoy et al., Fatty acids -induced lipotoxicity and inflammation, Curr. Drug Metab, vol.13, pp.1358-1370, 2012.

R. A. Schlegel, M. Stevens, K. Lumley-sapanski, and P. Williamson, Altered lipid packing identifies apoptotic thymocytes, Immunol. Lett, vol.36, pp.283-288, 1993.

V. K. Senanayake, W. Jin, A. Mochizuki, B. Chitou, and D. B. Goodenowe, Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study, BMC Neurol, vol.15, issue.154, 2015.

F. Sesti, S. Liu, and S. Q. Cai, Oxidation of potassium channels by ROS: a general mechanism of aging and neurodegeneration?, Trends Cell Biol, vol.20, pp.45-51, 2010.

F. Sesti, Oxidation of K(+) channels in aging and neurodegeneration, Aging Dis, vol.7, pp.130-135, 2016.

I. Singh, A. E. Moser, H. W. Moser, and Y. Kishimoto, Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes, Pediatr. Res, vol.18, pp.286-290, 1984.

M. Y. Sun, Y. Izumi, A. Benz, C. F. Zorumski, and S. Mennerick, Endogenous 24S-hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices, J. Neurophysiol, vol.115, pp.1263-1272, 2016.
DOI : 10.1152/jn.00890.2015

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808088/pdf

M. J. Sung, H. S. Ahn, S. J. Hahn, and B. H. Choi, Open channel block of Kv3. 1 currents by fluoxetine, J. Pharmacol. Sci, vol.106, pp.38-45, 2008.

L. Tang, Y. Wang, T. Leng, H. Sun, Y. Zhou et al., Cholesterol metabolite cholestane-3b, 5a, 6b-triol suppresses epileptic seizures by negative modulation of voltage-gated sodium channels, Steroids, vol.98, pp.166-172, 2015.

G. Testa, E. Staurenghi, C. Zerbinati, S. Gargiulo, L. Iuliano et al., Changes in brain oxysterols at different stages of Alzheimer's disease: their involvement in neuroinflammation, Redox Biol, vol.10, pp.24-33, 2016.

M. Tewari and P. Seth, Emerging role of P2X7 receptors in CNS health and disease, Ageing Res. Rev, vol.24, pp.328-342, 2015.

A. Vejux and G. Lizard, Cytotoxic effects of oxysterols associated with human diseases Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis, Mol. Asp. Med, vol.30, pp.153-170, 2009.

A. Vejux, S. Guyot, T. Montange, J. Riedinger, E. Kahn et al., Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterolinduced apoptosis, Nutr. Biochem, vol.20, pp.45-61, 2009.

P. A. Verhoef, M. Estacion, W. Schilling, and G. R. Dubyak, P2X7 receptordependent blebbing and the activation of Rho-effector kinases caspases, and IL-1 beta release, J. Immunol, vol.170, pp.5728-5738, 2003.

V. M. Vitvitsky, S. K. Garg, R. F. Keep, R. L. Albin, and R. Banerjee, Na+ and K+ ion imbalances in Alzheimer's disease, Biochim. Biophys. Acta, vol.1822, pp.1671-1681, 2012.
DOI : 10.1016/j.bbadis.2012.07.004

URL : https://doi.org/10.1016/j.bbadis.2012.07.004

T. Wald, I. Petry-podgorska, R. Fiser, T. Matousek, J. Dedina et al., Quantification of potassium levels in cells treated with Bordetella adenylate cyclase toxin, Anal. Biochem, vol.450, pp.57-62, 2014.

D. Weber, Z. Ni, D. Vetter, R. Hoffmann, and M. Fedorova, Electrochemical oxidation of cholesterol: an easy way to generate numerous oxysterols in short reaction times, Eur. J. Lipid Sci. Technol, vol.118, pp.325-331, 2016.

W. G. Wood, L. Li, W. E. Müller, and G. P. Eckert, Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis, J. Neurochem, vol.129, pp.559-572, 2014.
DOI : 10.1111/jnc.12637

URL : https://www.onlinelibrary.wiley.com/doi/pdf/10.1111/jnc.12637

M. Yamaguchi, Y. Tomiyama, T. Katayama, H. Kitahata, and S. Oshita, Involvement of adenosine triphosphate-sensitive potassium channels in the response of membrane potential to hyperosmolality in cultured human aorta endothelial cells, Anesth. Analg, vol.100, pp.419-426, 2005.

S. Y. Yeung, J. A. Millar, and A. Mathie, Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine, Br. J. Pharmacol, vol.128, pp.1609-1615, 1999.

Y. Yoshida, S. Kodai, S. Takemura, Y. Minamiyama, and E. Niki, Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples, Anal. Biochem, vol.379, pp.105-115, 2008.

A. Zarrouk, A. Vejux, T. Nury, H. I. El-hajj, M. Haddad et al., Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E), Oxid. Med. Cell Longev, p.623257, 2012.

A. Zarrouk, A. Vejux, J. Mackrill, Y. O'callaghan, M. Hammami et al., Involvement of oxysterols in age-related diseases and ageing processes, Ageing Res. Rev, vol.18, pp.148-162, 2014.

A. Zarrouk, T. Nury, A. Dauphin, P. Frère, J. Riedinger et al., Impact of C24:0 on actinmicrotubule interaction in human neuronal SK-N-BE cells: evaluation by FRET confocal spectral imaging microscopy after dual staining with rhodaminephalloidin and tubulin tracker green, Funct. Neurol, vol.30, pp.33-46, 2015.

A. Zarrouk, T. Nury, M. Samadi, Y. O'callaghan, M. Hammami et al., Effects of cholesterol oxides on cell death induction and calcium increase in human neuronal cells (SK-N-BE) and evaluation of the protective effects of docosahexaenoic acid, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01518107

, Steroids, vol.99, pp.238-247

A. Zarrouk, J. M. Riedinger, S. H. Ahmed, S. Hammami, W. Chaabane et al., Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia, J. Alzheimers Dis, vol.44, pp.1349-1359, 2015.

S. Zhornitsky, K. A. Mckay, L. M. Metz, C. E. Teunissen, and M. Rangachari, Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes, Mult. Scler. Relat. Disord, vol.5, pp.53-65, 2016.

C. F. Zorumski and Y. Izumi, NMDA receptors and metaplasticity: mechanisms and possible roles in neuropsychiatric disorders, Neurosci. Biobehav. Rev, vol.36, pp.989-1000, 2012.
DOI : 10.1016/j.neubiorev.2011.12.011

URL : http://europepmc.org/articles/pmc3288588?pdf=render

G. R. De-lores-arnaiz, M. G. Ordieres, C. Van-de-kraats, J. Killestein, V. Popescu et al., Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis, Journal: Journal of Cellular Biochemistry Manuscript ID Draft Wiley, vol.10, pp.412-417, 2014.

A. ;. Zarrouk, . Univ, and . Monastir, Lab-NAFS 'Nutrition -Functional Food & Vascular Health' MAATOUG, Sonia; Univ, Lab. 'Venoms & Therapeutic Biomolecules', vol.12, p.158

B. Hycel and L. , Belgium) with a propane flame; lithium was used as an internal standard

, After 24 h of culture, cells were treated for 24 h with either oxysterols, vol.7, p.25

G. ?m-;-astarita, K. M. Jung, V. Vasilevko, N. V. Dipatrizio, S. K. Martin et al., ); ref: sc-514554; mouse monoclonal (Sigma-Aldrich); ref: SAB5200030 (anti-kv3each sample, 10,000 cells were acquired, and the data were analyzed with Flomax (Partec) or FlowJo REFERENCES, or C24fluorescence microscopy, respectively. Cells were collected, washed in PBS, 1% BSA, 0.1% NaN 3 , resuspended in PBS, and fixed in freshly prepared 2% (w/v) pformaldehyde diluted in PBS (pH 7.4), vol.6, 2011.

M. Baarine, P. Andréoletti, A. Athias, T. Nury, A. Zarrouk et al., Evidence of oxidative stress in very long chain fatty acid-treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins, Neuroscience, vol.213, pp.1-18, 2012.

M. Baarine, K. Ragot, E. C. Genin, E. Hajj, H. Trompier et al.,

F. Menetrier, M. Cherkaoui-malki, S. Savary, and G. Lizard, Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): potential models for the study of peroxisomal disorders associated with dysmyelination processes, Neurochem, vol.111, pp.119-131, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00514890

N. Baumann and D. Pham-dinh, Biology of oligodendrocyte and myelin in the mammalian central nervous system, Physiol Rev, vol.81, pp.871-927, 2001.

I. Björkhem and S. Meaney, Brain cholesterol: long secret life behind a barrier, Arterioscler Thromb Vasc Biol, vol.24, pp.806-815, 2004.

I. Björkhem, Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain, Intern Med, vol.260, pp.493-508, 2006.

E. Boda, E. Hoxha, A. Pini, F. Montarolo, and F. Tempia, Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease, J Mol Neurosci, vol.46, pp.606-615, 2012.

S. Boenzi, F. Deodato, R. Taurisano, B. M. Goffredo, C. Rizzo et al., Evaluation of plasma cholestane-3?,5?,6?-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism, Lipid Res, vol.57, pp.361-367, 2016.

C. Bortner and J. Cidlowski, Cell shrinkage and monovalent cation fluxes: role, in apoptosis, Arch Biochem Biophys, vol.462, pp.176-188, 2007.
DOI : 10.1016/j.abb.2007.01.020

URL : http://europepmc.org/articles/pmc1941616?pdf=render

C. Bortner, M. Gómez-angelats, and J. A. Cidlowski, Plasma membrane depolarization without repolarization is an early molecular event in anti-Fas-induced apoptosis, J Biol Chem, vol.276, p.4304, 2001.

N. Braverman and A. Moser, Functions of plasmalogen lipids in health and disease, Biochim Biophys Acta, vol.1822, pp.1442-1452, 2012.

P. Brites, H. R. Waterham, and R. J. Wanders, Functions and biosynthesis of plasmalogens in health and disease, Biochim Biophys Acta, vol.22, pp.219-231, 2004.

S. Q. Cai and F. Sesti, Oxidation of a potassium channel causes progressive sensory function loss during aging, Nat Neurosci, vol.12, pp.611-617, 2009.

Z. Cai and M. Xiao, Oligodendrocytes and Alzheimer's disease, Int J Neurosci, vol.126, pp.97-104, 2016.

E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, pp.921-923, 1993.

D. Cotella, B. Hernandez-enriquez, X. Wu, R. Li, Z. Pan et al.,

, Toxic role of K+ channel oxidation in mammalian brain, J Neurosci, vol.32, pp.4133-4144

P. J. Crick, W. J. Griffiths, J. Zhang, M. Beibel, J. Abdel-khalik et al., , 2016.

, Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients, Mol Neurobiol

C. L. Deckers, A. B. Lyons, K. Samuel, A. Sanderson, and A. H. Maddy, Alternative pathways of apoptosis induced by methylprednisolone and valinomycin analyzed by flow cytometry, Exp Cell Res, vol.208, pp.362-370, 1993.

M. Doria, L. Maugest, T. Moreau, G. Lizard, and A. Vejux, Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease. Free Radic, Biol. Med, vol.101, pp.393-400, 2016.

M. J. Duran, S. V. Pierre, P. Lesnik, G. Pieroni, M. Bourdeaux et al., 7-ketocholesterol inhibits Na,K-ATPase activity by decreasing expression of its ?1-subunit and membrane fluidity in human endothelial cells, Cell Mol Biol, p.56, 2010.

B. Ettle, J. C. Schlachetzki, and J. Winkler, Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?, Mol Neurobiol, vol.53, pp.3046-3062, 2016.

A. C. Feutz, D. Pham-dinh, B. Allinquant, M. Miehe, and M. S. Ghandour, An immortalized jimpy oligodendrocyte cell line: defects in cell cycle and cAMP pathway, Glia, vol.34, pp.241-252, 2001.

S. Franciosi, J. K. Ryu, H. B. Choi, L. Radov, S. U. Kim et al., Broad-spectrum effects of 4-aminopyridine to modulate amyloid beta1-42-induced cell signaling and functional responses in human microglia, J Neurosci, vol.26, pp.11652-11664, 2006.

R. Franco, C. D. Bortner, and J. A. Cidlowski, Potential roles of electrogenic ion transport and plasma membrane depolarization in apoptosis, J Membr Biol, vol.209, pp.43-58, 2006.

P. Gamba, G. Testa, S. Gargiulo, E. Staurenghi, G. Poli et al., Oxidized cholesterol as the driving force behind the development of Alzheimer's disease, Front Aging Neurosci, vol.7, p.119, 2015.

S. Hadavi, M. D. Baker, and R. Dobson, Sustained-release fampridine in multiple sclerosis, Mult Scler Relat Disord, vol.3, pp.17-21, 2017.

J. R. Hascalovici, J. Vaya, S. Khatib, C. A. Holcroft, H. Zukor et al., Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1, Neurochem, vol.110, pp.1241-1253, 2009.

S. Hein, P. Schönfeld, S. Kahlert, and G. Reiser, Toxic effects of X-linked adrenoleukodystrophyassociated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture, 2008.

, Hum. Mol. Genet, vol.17, pp.1750-1761

Y. Inai, M. Yabuki, T. Kanno, J. Akiyama, T. Yasuda et al., Valinomycin induces apoptosis of ascites hepatoma cells (AH-130) in relation to mitochondrial membrane potential, 1997.

, Cell Struct Funct, vol.22, pp.555-563

J. Jang, S. Park, J. Hur, H. Cho, H. J. Hwang et al., 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome, Nat Commun, vol.7, p.13129, 2016.

T. M. Jeitner, I. Voloshyna, and A. B. Reiss, Oxysterol derivatives of cholesterol in neurodegenerative disorders, Curr Med Chem, vol.18, pp.1515-1525, 2011.

R. H. Joho and E. C. Hurlock, The role of Kv3-type potassium channels in cerebellar physiology and behavior, Cerebellum, vol.8, pp.323-333, 2009.

B. Klein, K. Wörndl, U. Lütz-meindl, and H. H. Kerschbaum, Perturbation of intracellular K(+), vol.16, pp.1101-1117, 2011.

H. Kölsch, D. Lütjohann, A. Tulke, I. Björkhem, and M. L. Rao, The neurotoxic effect of 24-hydroxycholesterol on SH-SY5Y human neuroblastoma cells, Brain Res, vol.818, pp.171-175, 1999.

J. Kou, G. G. Kovacs, R. Höftberger, W. Kulik, A. Brodde et al., Peroxisomal alterations in Alzheimer's disease, Acta Neuropathol, vol.122, pp.271-283, 2011.

F. Kreilaus, A. S. Spiro, C. A. Mclean, B. Garner, and A. M. Jenner, Evidence for altered cholesterol metabolism in Huntington's disease post mortem brain tissue, Neuropathol Appl Neurobiol, vol.42, pp.535-546, 2016.

N. Kruska, P. Schönfeld, A. Pujol, and G. Reiser, Astrocytes and mitochondria from adrenoleukodystrophy protein (ABCD1)-deficient mice reveal that the adrenoleukodystrophyassociated very long-chain fatty acids target several cellular energy-dependent functions, 2015.

, Biochim Biophys Acta, vol.1852, pp.925-936

K. Kunzelmann, Ion channels in regulated cell death, Cell Mol Life Sci, vol.73, pp.2387-2403, 2016.

V. Leoni and C. Caccia, 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases, Biochimie, vol.95, pp.595-612, 2013.

C. J. Luneau, J. B. Williams, J. Marshall, E. S. Levitan, C. Oliva et al., Alternative splicing contributes to K+ channel diversity in the mammalian central nervous system, Proc Natl Acad Sci, vol.88, pp.3932-3936, 1991.

D. Lütjohann, A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli et al., Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients, J Lipid Res, vol.41, p.195, 2000.

J. J. Mackrill, Oxysterols and calcium signal transduction, Chem. Phys. Lipids, vol.164, pp.488-495, 2011.

F. R. Maxfield and I. Tabas, Role of cholesterol and lipid organization in disease, Nature, vol.438, pp.612-621, 2005.

F. R. Maxfield and I. Tabas, Role of cholesterol and lipid organization in disease, Nature, vol.438, pp.612-621, 2005.

S. Mukhopadhyay, K. Fellows, R. W. Browne, P. Khare, S. Krishnan-radhakrishnan et al., Interdependence of oxysterols with cholesterol profiles in multiple sclerosis, Mult Scler, 2016.

V. Mutemberezi, O. Guillemot-legris, and G. G. Muccioli, Oxysterols: From cholesterol metabolites to key mediators, Prog Lipid Res, vol.64, pp.152-169, 2016.

N. Noguchi, Y. Urano, W. Takabe, and Y. Saito, New aspects of 24S-hydroxycholesterol inmodulating neuronal cell death, Free Radic Biol Med, vol.87, pp.366-372, 2015.

T. Nury, A. Zarrouk, A. Vejux, M. Doria, J. M. Riedinger et al., Induction of oxiapoptophagy, a mixed mode of cell death associated with oxidative stress, apoptosis and autophagy, on 7-ketocholesterol-treated 158N murine oligodendrocytes: impairment by ?-tocopherol, Biochem Biophys Res Commun, vol.446, pp.714-719, 2014.

T. Nury, A. Zarrouk, J. J. Mackrill, M. Samadi, P. Durand et al., Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7?-hydroxycholesterol-, or 24(S)-hydroxycholesterol: Protective effects of ?-tocopherol and docosahexaenoic acid, Steroids, vol.99, pp.194-203, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01518110

T. Nury, A. Zarrouk, K. Ragot, M. Debbabi, J. M. Riedinger et al., 7-Ketocholesterol is increased in the plasma of X-ALD patients and induces peroxisomal modifications in microglial cells: Potential roles of 7-ketocholesterol in the pathophysiology of X-ALD, J Steroid Biochem. Mol. Biol, issue.16, pp.30094-30096, 2016.

E. Olivier, M. Dutot, A. Regazzetti, T. Leguillier, D. Dargère et al., , 2016.

, P2X7-pannexin-1 and amyloid ?-induced oxysterol input in human retinal cell: Role in agerelated macular degeneration, Biochimie, vol.127, pp.70-78

V. M. Olkkonen and R. Hynynen, Interactions of oxysterols with membranes and proteins, Mol Aspects Med, vol.30, pp.123-156, 2009.

A. Ozaita, M. E. Martone, M. H. Ellisman, and R. B. , Differential subcellular localization of the, 2002.

F. Panza, D. 'introno, A. Colacicco, A. M. Capurso, C. Pichichero et al., Lipid metabolism in cognitive decline and dementia, Brain Res Rev, vol.51, p.275, 2006.

T. M. Perney, J. Marshall, K. A. Martin, S. Hockfield, and L. K. Kaczmarek,

. Neurophysiol, , vol.68, pp.756-766

A. M. Petrov, M. R. Kasimov, and A. L. Zefirov, Brain cholesterol metabolism and its defects: linkage to neurodegenerative diseases and synaptic dysfunction, Acta Naturae, vol.8, pp.58-73, 2016.

L. Pini, M. Pievani, M. Bocchetta, D. Altomare, P. Bosco et al., Brain atrophy in Alzheimer's Disease and aging, Ageing Res Rev, vol.30, pp.25-48, 2016.

L. D. Plant, J. P. Boyle, N. M. Thomas, N. J. Hipkins, E. Benedikz et al., Presenilin-1 mutations alter K + currents in the human neuroblastoma cell line, SH-SY5Y, Neuroreport, vol.13, pp.1553-1556, 2002.

J. Popp, S. Meichsner, H. Kölsch, P. Lewczuk, W. Maier et al.,

, Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease, Biochem Pharmacol, vol.86, pp.37-42

F. D. Porter, D. E. Scherrer, M. H. Lanier, S. J. Langmade, V. Molugu et al.,

, Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease, Sci Transl Med, vol.2, pp.56-81

K. Ragot, J. J. Mackrill, A. Zarrouk, T. Nury, V. Aires et al., Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes, Biochem. Pharmacol, vol.86, pp.67-79, 2013.

M. Romanello, S. Zampieri, N. Bortolotti, L. Deroma, A. Sechi et al., Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3?,5?,6?-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations, Clin Chim Acta, vol.455, pp.39-45, 2016.

G. Rothe and G. Valet, Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2',7'-dichlorofluorescin, J Leukoc Biol, vol.47, pp.440-448, 1990.

B. Rudy, A. Chow, D. Lau, Y. Amarillo, A. Ozaita et al., Contributions of Kv3 channels to neuronal excitability, vol.868, pp.304-343, 1999.

B. Rudy and C. J. Mcbain, Kv3 channels: voltage-gated K+ channels designed for highfrequency repetitive firing, Trends Neurosci, vol.24, pp.517-526, 2001.

D. W. Russell, R. W. Halford, D. M. Ramirez, R. Shah, and T. Kotti, Cholesterol 24-hydroxylase: an enzyme of cholesterol turnover in the brain, Annu Rev Biochem, vol.78, pp.1017-1040, 2009.

P. Schönfeld and G. Reiser, Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids. Harmful Cellular/Mitochondrial Activities in Refsum Disease and X-Linked Adrenoleukodystrophy, Aging Dis, vol.7, pp.136-149, 2016.

V. K. Senanayake, J. W. Mochizuki, A. Chitou, B. Goodenowe, and D. B. , Metabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control study, BMC Neurol, vol.15, p.154, 2015.

F. Sesti, Oxidation of K (+) Channels in Aging and Neurodegeneration, Aging Dis, vol.7, p.130, 2016.

R. J. Wanders, S. Ferdinandusse, P. Brites, and S. Kemp, Peroxisomes, lipid metabolism and lipotoxicity, Biochim Biophys Acta, vol.1801, pp.272-280, 2010.

R. J. Wanders, Metabolic functions of peroxisomes in health and disease, Biochimie, vol.98, p.36, 2014.

T. Wei, M. Yi, W. Gu, L. Hou, Q. Lu et al., The Potassium Channel, vol.3, 2017.

, Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease, Front Pharmacol, vol.7, p.528

M. Weiser and E. Vega-saenz-de-miera,

B. , Differential expression of Shaw-related K+ channels in the rat central nervous system, J Neurosci, vol.14, pp.949-972, 1994.

W. G. Wood, L. Li, W. E. Müller, and G. P. Eckert, Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis, J Neurochem, vol.129, pp.559-572, 2014.

C. Y. Wu, C. Kaur, V. Sivakumar, J. Lu, and E. A. Ling, Kv1.1 expression in microglia regulates production and release of proinflammatory cytokines, endothelins and nitric oxide, Neuroscience, vol.158, pp.1500-1508, 2009.

Y. H. Wu, D. Arnaud-cormos, M. Casciola, J. M. Sanders, P. Leveque et al., Moveable wire electrode microchamber for nanosecond pulsed electric-field delivery, IEEE Trans Biomed Eng, vol.60, pp.489-496, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00906767

R. S. Yadav and N. K. Tiwari, Lipid integration in neurodegeneration: an overview of Alzheimer's disease, J Mol Neurobiol, vol.50, pp.168-176, 2014.

J. R. Yaron, S. Gangaraju, M. Y. Rao, X. Kong, L. Zhang et al.,

, K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells, Cell Death Dis, vol.6, p.1954

S. P. Yu, C. H. Yeh, S. L. Sensi, B. J. Gwag, L. M. Canzoniero et al., Mediation of neuronal apoptosis by enhancement of outward potassium current, Science, vol.278, pp.114-117, 1997.

S. P. Yu, Regulation and critical role of potassium homeostasis in apoptosis, Prog Neurobiol, vol.70, pp.363-386, 2003.

A. Zarrouk, A. Vejux, J. Mackrill, Y. O'callaghan, M. Hammami et al., Involvement of oxysterols in age-related diseases and ageing processes, Ageing Res Rev, vol.18, p.148, 2014.

A. Zarrouk, M. Hammami, T. Moreau, and G. Lizard, Accumulation of 24S-hydroxycholesterol in neuronal SK-N-BE cells treated with hexacosanoic acid(C26:0): argument in favor, pp.24-40, 2015.

, Rev Neurol, vol.171, p.125

A. Zarrouk, J. M. Riedinger, S. H. Ahmed, S. Hammami, W. Chaabane et al., Fatty acid profiles in demented patients: identification of hexacosanoic acid (C26:0) as a blood lipid biomarker of dementia, J Alzheimers Dis, vol.44, pp.1349-1359, 2015.

A. Zarrouk, T. Nury, A. Dauphin, P. Frère, J. M. Riedinger et al., Impact of C24:0 on actin-microtubule interaction in human neuronal SK-N-BE cells: evaluation by FRET confocal spectral imaging microscopy after dual staining with rhodamine-phalloidin and tubulin tracker green, Funct. Neurol, vol.30, pp.33-46, 2015.

A. Zarrouk, T. Nury, M. Samadi, Y. O'callaghan, M. Hammami et al., Effects of cholesterol oxides on cell death induction and calcium increase in human neuronal cells (SK-N-BE) and evaluation of the protective effects of docosahexaenoic acid (DHA; C22:6 n-3), Steroids, vol.99, pp.238-247, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01518107

S. Zhornitsky, K. A. Mckay, L. M. Metz, C. E. Teunissen, and M. Rangachari, Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes, 2016.

, Mult Scler Relat Disord, vol.5, pp.53-65